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Abstract 
Voltage-gated ion channels are vital components to the process of signal 
transmission in nerve cells. They constitute an inviting target for the 
development of drugs which target aberrant pain signal transmission. Voltage-
gated potassium channels are an essential component in signalling along 
neural pathways, as their role in restoring resting membrane potential in nerve 
cells is crucial to priming neurons for further signal transmission following 
membrane depolarisation. 
In this thesis, work towards developing a structural understanding of 
interactions between the human Kv1.1 voltage-gated potassium channel and 
inhibitory molecules will be discussed. This project has involved the 
development of expression vectors and cell lines for expression of Kv1.1 in 
human cell cultures, as well as experimentation with methods for extracting 
the protein with recently developed maleic-acid polymers SMA and DIBMA, 
which retain the native lipid envelop surrounding the channel complex. The 
extracted protein has been analysed through both biochemical 
characterisation though mass spectrometry and circular dichroism 
spectroscopy, as well as structural studies conducted through both negative 
stain and cryo-EM, resulting a low-resolution model from negative stain. 
This work lays the foundation for future investigation of the human Kv1.1 
channel, providing tested means and methodologies for the production of 
proteins in human cell expression systems, extraction through non-detergent 
methods and their analysis via cryo-electron microscopy.  
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1 Introduction 
1.1 Integral membrane proteins and plasma 
membranes 
1.1.1 Overview 
Plasma membranes are a ubiquitous and essential feature of all cellular 
organisms; these structures are crucial to forming the boundaries of organic 
bodies, creating a barrier which encapsulates and holds together the 
machinery and pathways of the cell, while protecting them from perturbations 
in the external environment. Plasma membranes are formed from a collection 
of amphipathic, lipid-based molecules, most often phospholipids though 
occasionally glycolipids, which arrange into a bilayer. The hydrophilic 
phosphate or sugar groups are orientated outward, facing into the surrounding 
aqueous environment, with the hydrophobic lipid groups of both layers 
arranged in parallel, facing tail-to-tail (Maibaum et al. 2004). 
Cellular membranes are not simple, impenetrable walls, however; they are 
complex, intricate systems in their own right. The plasma membranes of all 
cells are composed of a rich assortment of phospholipids, integral membrane 
proteins and sugar groups, all of which work in coordination for a variety of 
tasks (Van Meer et al. 2008). In animals, sphingolipids, such as sphingomyelin 
and sphingomyolin, have been known to form lipid raft structures, which help 
to compartmentalise the membrane (Kinoshita et al. 2018). 
Membranes have a selective permeability to allow essential nutrients and 
signals from the outside world into the cell. Many of the processes which occur 
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at and across cell membranes are conducted by integral membrane proteins 
which are embedded in the lipid bilayer. 
1.1.2 Challenges associated with membrane protein study 
1.1.2.1 Membrane protein expression 
Identifying and developing systems for expressing proteins is the first step in 
production of materials for structural study. Host systems must be able to 
produce correctly folded, functional samples in quantities of the order of 
milligrams for structural characterisation (for example, X-ray crystallography 
and NMR) (Kim, Y. et al. 2008). This requires expression machinery which is 
able to recognise motifs in the peptide sequence and chaperone the nascent 
protein so that it can fold to form a functional final product. The expression 
machinery must also be able to handle a high volume of transcripts and 
translated peptide chains to avoid the generation of misfolded protein, both 
for the sake of efficiency, as well as to avoid fatally over-encumbering waste 
disposal pathways (Klepsch et al. 2011). 
Historically, many soluble proteins from bacterial, archaea and eukaryotes 
have been expressed for study using well-characterised model Gram-
negative bacterium Escherichia coli for fast and reliable generation of 
samples, thanks to its ease of manipulation and fast doubling time (Postis, V. 
G. et al. 2013). Thanks to modified plasmid vectors, E. coli cells have been 
used extensively to express proteins from across the tree of life (Choi et al. 
2006). 
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The study of eukaryotic integral membrane proteins, however, is often beset 
by more problems than their soluble counterparts. One of the chief issues 
being incompatibilities between the machinery required for native membrane 
proteins targeting and folding with bacterial expression systems in transgenic 
expression. Expression of eukaryotic proteins is exceptionally challenging in 
bacterial systems due to fundamental differences in the structure and 
composition of both cell membranes and expression machinery (Kota and 
Ljungdahl 2005, Postis, V. G. et al. 2013). 
Membrane proteins bring their own unique challenges in generating proteins 
that are both stable, folded and functional for research. Firstly, targeting and 
insertion of mammalian membrane proteins into lipid bilayers is often 
governed by a complex interaction between stop-transfer membrane-anchor 
targeting motifs near the N-terminus of protein primary sequence and internal 
translation and chaperon machinery such as Signal Recognition Particle, 
Hsc70/Hsp70 or Asna-1/TRC40 at the endoplasmic reticulum of the cell (Rabu 
and High 2007, Janda et al. 2010). Disruption to any of the elements involved 
in this process can result in misfolding of the proteins (Popot, J L and 
Engelman 2000). 
Overexpression of membrane proteins can also be hazardous for the host cell. 
Overexpression of membrane proteins can overwhelm protein folding 
machinery within the cell, leading to build of up of toxic aggregates. The 
presence of excessive number of channel proteins or pumps can cause lethal 
disruptions to the normal balance of nutrients, salts and/or pH of the cytosol 
by allowing aberrant exchange of molecules or ions with the extracellular 
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environment. Therefore, expressing channels/transporters that are 
constitutively active may require inhibitors to prevent killing of the host cell.  
Additionally, cell membranes are effectively 2-dimensional spaces, as 
opposed to the 3-dimensional spaces of the cytosol. This gives membrane 
proteins significantly less space to diffuse and travel, as well as making 
overpopulation and overcrowding hazardous to the functioning of the 
membrane. Many membrane structures which influence membrane-
associated proteins, such as curvature and the formation of rafts, can be 
dependent on the presence of specific of membrane proteins. 
1.1.3 Methods for membrane protein extraction 
1.1.3.1 Detergents 
The most common approach for the extraction of membrane proteins is to 
emulsify the lipid bilayer using detergents, such as n-dodecyl-β-D-
maltopyranoside (DDM) (Vanaken et al. 1986). Detergent molecules are a 
popular choice for dissolving lipid bilayers in order to liberate embedded 
proteins as the have very similar characteristics to lipids; both being 
amphipathic molecules with polar head groups connected to longer, 
hydrophobic tails (Gohon and Popot, J.-L. 2003). As such, they similarly form 
micelle structures which are able to substitute the membrane around an 
integral membrane protein, effectively forming a ‘belt’ which can stably house 
the protein. 
The traditional model for membrane disruption by detergent, commonly 
referred to as the Three-Stage Model, states that lipid bilayers are disrupted 
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by the insertion of detergents into the monolayers of the membrane. In the 
first stage, the introduction of further molecules into the membrane results in 
increased packing of the molecules and increasing the turbidity of molecules 
in the membrane. In the second stage, the addition of detergent leads to and 
increase in the curvature of the membrane, leading to curvature stress which 
causes the membrane to bulge. Finally, in the third stage, as the ratio of 
detergent to native lipid increases further, the membrane bulge completely 
decouples from the opposing monolayer, rapidly sealing off and leaving the 
membrane as a miscelle (Lichtenberg et al. 2013). 
Detergents are broadly classified into 4 primary groups: ionic detergents (e.g. 
sodium dodecyl sulphate [SDS]), non-ion detergents (e.g. DDM), zwitterionic 
detergents (e.g. 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate [CHAPS]) and bile salt detergents (Lund et al. 1989, 
Seddon et al. 2004). Each detergent type has its own strengths and 
weaknesses, with non-ionic and bile salt detergents being relatively mild and 
ionic detergents generally being harsh, often disrupting the protein’s local 
environment and fold by changing the local electrical charges (Lund et al. 
1989). 
1.1.3.2 Maleic acid polymers 
While detergents are popular and easy to use, with multiple well-established 
protocols for their use, they are not optimal for the extraction of membrane 
proteins. Detergent molecules substitute for natural lipids in the micelle, 
removing natively associated molecules, such as cholesterols, which can be 
essential for protein folding and function. In such cases, detergent-free 
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methods which preserve natively associated lipid molecules around the 
protein. 
Styrene maleic acid polymers have reached prominence in recent years for 
their capacity to quickly and consistently form lipid nanodiscs, which are 
capable of encapsulating integral membrane proteins in preserved segment 
of bilayer (Postis, V. et al. 2015) (Figure 1.1). The extracted membrane 
segment, encapsulated by SMA, is referred to as an SMA lipid particle 
(SMALP). 
 
 
Figure 1.1 – Cartoon representation of integral membrane proteins 
extraction the maleic acid polymer SMA. 
 
SMA has displayed success in extracting ABC transporters and bacterial 
potassium channel proteins for membranes, with the former displaying activity 
comparable to that of the native environment once extracted, displaying their 
capacity for retaining native fold and functionality (Gulati et al. 2014, Dörr et 
al. 2014). Such properties make SMA a very enticing target for study, as this 
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in theory allows proteins to be studied in states much closer to the native state 
than is afforded by traditional detergent-based methods. 
Diisobutylene maleic acid (DIBMA), a polymer similar to SMA, has recently 
been reported as being able to form similar nanodisc structures of cellular lipid 
bilayers, simultaneously encapsulating membrane proteins (Oluwole et al. 
2017b) (Figure 1.2). DIBMA and DIBMA lipid particles (DIBMALPs) containing 
membrane proteins have several advantages over SMA, such as reduced 
absorbance in the far-UV segment of the spectrum, reduced effects on lipid 
acyl chain ordering and lower susceptability to aggregation in the presence of 
divalent cations (Oluwole et al. 2017a). 
 
 
Figure 1.2 – Diagrams of the chemical structures of SMA and DIBMA 
polymers. Figure adapted from (Oluwole et al. 2017a). 
 
Research of DIBMALPs is currently in its infancy; as of the time of writing, no 
materials have yet been published on the structure of any protein extracted in 
DIBMA, nor has any data been published characterising or probing the 
stability of proteins in DIBMA-based nanodiscs. DIBMA is of particular interest 
Styrene maleic acid (SMA) Diisobutylene maleic acid (DIBMA)
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at present thanks to its lack of intellectual property (IP) restrictions which 
currently apply to SMA, allowing for more flexibility in its discussion and 
application. 
1.2 Cation channel superfamily 
1.2.1 Overview 
The formation and maintenance of concentration gradients across lipid 
membranes is a common feature of cellular organisms. Gradients of cations 
are used in a wide range of physiological activities, such as the storage of 
energy as electrochemical potential to drive oxidative phosphorylation of ADP 
in the case of ATP synthesis and transduction of signals along and between 
neuronal cells (Ostroumov et al. 1979, Dimroth et al. 2000). 
The formation of such concentration inequities requires the cooperative 
function of a series of ion pump and channel proteins, which promote an 
ordered uptake and secretion of a series of ions to generate and dissipate 
electrochemical gradients (Gouaux and Mackinnon 2005). 
In resting neurons, K+ are maintained at an intracellular concentration of 155 
mM, compared to concentrations of 4 mM in the extracellular environment 
(Hille 2001). The net effect of the electrochemical gradients of each of these 
ion types creates a resting potential across the membrane of -70 mV (Hille 
2001). 
The cation channel superfamily constitutes a large and varied group of integral 
membrane proteins which facilitate the passive transport of ions across lipid 
bilayers, conducting them down their electrochemical gradients. Members of 
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the cation channel superfamily share a number of common architectural 
features which are conserved across all three domains of life (Hille 2001). 
Their functions are essential to a wide variety of cellular processes, ranging 
from signalling and transport to maintaining homeostasis of essential cell 
nutrients. 
1.2.2 Voltage-gated potassium channels 
Voltage-gated potassium channels (Kv channels) are a vital component of 
many signalling systems, playing a crucial role in mediating electrochemical 
signalling through neuronal and smooth muscle cells. Kv channels sense the 
difference in charge across the plasma membrane, coupling the state of the 
cell’s membrane potential to the channel’s conformational state. Kv channels, 
when activated, act as an ion conduit, allowing K+ to flow out of the cell from 
the intracellular environment, driven by the electrochemical gradient. 
Kv channels are activated in response to membrane depolarisation (Figure 
1.3); when the activation potential of the channel is reached, the channel shifts 
its conformation which allows greater conductance of potassium ions across 
the lipid bilayer, allowing intracellular K+ ions to diffuse out of the cell down 
their electrochemical gradient. The outward flow of positive charge along with 
the potassium ions causes a shift in membrane potential back towards a 
negative value and the resting potential of the cell (typically approximately -70 
mV) is re-established (Lewis et al. 2011). Once the membrane potential of the 
cell has returned to its resting state, the Kv channel is deactivated (Hille 2001). 
K+ channels are the largest family of ion channels in the human genome, with 
over 70 genes in total (González et al. 2012, Humphries and Dart, C. 2015). 
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The Kv1 channel (KCNA) subfamily of voltage-gated potassium channels 
proteins are often referred to as Shaker-type channels. This nomenclature is 
derived from early in vivo studies of a homologous Kv channel gene in 
Drosophila melanogaster, which was dubbed Shaker after the shaking leg 
phenotype observed as a result of mutations in the gene (Tempel et al. 1987). 
All Kv channels are members of the larger voltage-gated ion channel 
superfamily, which includes all other potassium channel families, as well as 
Na+ and Ca2+ ion channel families and some H+ ion channels (Hille 2001). 
All Kv channels share a number of unique structural elements – early insights 
into the structure of the pore-forming domain of potassium channels came in 
the from a 3.2 Å X-ray crystal structure of the prokaryotic KcsA channel 
derived from Streptomyces lividans (Doyle et al. 1998). KcsA is a pH-sensitive 
potassium channel constructed from a symmetrical, tetrameric arrangement 
of integral membrane proteins, dubbed ‘α subunits’. While KcsA provided 
much information on the general architecture of potassium channel pores and 
the structural basis of their selectivity for K+ ions, it did not provide any 
information on the mechanism of voltage-gating in larger Kv channel α 
subunits. 
Each Kv1 α subunit features a soluble T1 domain at its N-terminal, followed 
by a series of 6 transmembrane helices, dubbed S1-S6, in order from N-
terminal to C-terminal. Kv channel α subunits are able to form both 
homotetramers, as well as heterotetramers with other proteins in the same 
family, such as the Kv1.1, Kv1.2 and Kv1.4 proteins of the Kv1 family (Figure 
1.3) (Jan, L. Y. and Jan, Y. N. 2012) 
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All voltage-gated cation channels, including Na+ and Ca2+, feature a highly 
conserved ~20 amino acid-long region, often dubbed the ‘P-loop’, which 
constitutes the selectivity filter of the channel. Conservation of the P-loop 
among all potassium ion channels is not limited to its amino acid sequence; 
the structure of the selectivity filter observed in mammalian Kv channel 
selectivity filters are virtually identical to the selectivity filter found in the 
distantly related bacterial K+ channel KcsA (Long et al. 2007). 
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Figure 1.3 – Cartoon representation of tetrameric Kv1.1 homology model (a) and schematic diagram of Kv1.1 monomer (b). The 
homology model featured in (a) was generated using the online Phyre2 server, with the structure of the Rattus norvegicus chimera 
Kv1.2-2.1 (PDB ID: 4JTC) used as the template for generating the homology model (Kelley et al. 2015, Banerjee et al. 2013).
P-loop 
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In Kv channels, the P-loop is located in the linker between helices S5 and S6 
(Figure 1.3). The backbone carbonyl groups face inward at the extracellular 
opening of channel, forming a series of 4 binding sites that coordinate K+ ions 
in a cubic geometry (Doyle et al. 1998). The diameter of each binding site is 
too small to accommodate ions larger than K+, such as Ca2+. Smaller ions, 
such as Na+, are excluded as their smaller size makes them unable to 
coordinate with all carbonyls at each ion-binding position, due to the 
octahedral geometry required for binding Na+ ions (Hille 2001). 
The use of backbone carbonyl groups in ion transport is crucial to the 
efficiency of the process. Carbonyl groups are sufficiently electronegative to 
dehydrate and bind K+, while also holding the ions weakly enough to keep the 
energetic cost of binding and release relatively low (Zhou, Y. et al. 2001). This 
system of selection is highly energy efficient; K+ ions are able to cross the 
membrane, allowing transport to occur at rates comparable to free diffusion. 
Gating of Kv channels is achieved through the movement of a voltage-sensor 
domain, which is formed from a helix-turn-helix motif comprising the C-
terminal portion of the S3 TM helix, the subsequent linker region and the 
following S4 TM helix (Stühmer et al. 1989, Frech et al. 1989, Long et al. 
2005). The voltage-sensor domain acts as a mobile paddle, which shifts in 
response to changes in voltage across the membrane (Long et al. 2007). It is 
the motion of this domain that couples the state of the cell’s membrane 
potential with the activity of the channel. 
Movement of the paddle in response to a positive membrane potential shifts 
the protein into a conformation which favours potassium conductance. This 
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sensitivity to voltage is conferred by a series of charged residues along the S4 
helix (Figure 1.3), which face into the hydrophobic core of the plasma 
membrane (Bezanilla, F 2000). The structure of the voltage-sensor domain is 
highly conserved across multiple voltage-sensitive ion channel families. In 
contract to the core sequence of the P-loop, however, the amino acid 
sequence of the voltage-sensor domain is considerably less well conserved, 
(Long et al. 2007). 
Drosophila Shaker Kv channels feature in-built inactivation domains located at 
their N-termini, which act in a ‘ball-and-chain’ fashion, binding to the 
intracellular opening of the channel for rapid inactivation of ion conduction; 
this form of regulation is referred to as N-type inactivation. The involvement of 
the α subunit N-terminal was confirmed by both proteolytic digestion and 
deletion of the first 22 amino acids of the protein (Armstrong and Bezanilla, 
Francisco 1973, Hoshi et al. 1990, Zagotta et al. 1990). Many mammalian Kv 
channels, including Kv1.1, do not possess an N-terminal inactivation domain, 
however (Hille 2001). 
Accessory proteins, known as β subunits, KCNAB, or Kvβ2, often modulate 
the activities of potassium channels.  β subunits are closely related to the aldo-
keto reductase subfamily of NADPH-dependent oxidoreductases, possessing 
NADPH-binding sites (Gulbis, Jacqueline M et al. 1999). β subunits co-
assemble with Shaker-type channels during translation and folding at the 
endoplasmic reticulum to form an octomeric complex, composed of the 
tetrameric pore formed from four α subunit and four β subunits (Gulbis, J M et 
al. 2000). Each Kvβ protein is associated with the T1 domain of an α subunit. 
The subunits then remain closely associated with cytoplasmic T1 domain of 
15 
 
the channel’s α subunits (Gulbis, J M et al. 2000).  Three β subunits are known 
to associate with Kv1 family channels: KCNAB1 (Kvβ1), KCNAB2 (Kvβ2) and 
KCNAB3 (Kvβ3); for example, the Kvβ2 subunit is known to co-localise and 
associate readily with Kv1.1 subunits (Rhodes et al. 1996). 
1.3 Pharmacology of Kv1.1 and related channels 
Shaker-type K+ channels are involved in a large number of biological process 
and diseases and many have been extensively studied as therapeutic targets. 
The identification and development of inhibitors for inappropriately active 
channels has become a large and active field of research. The Kv1.3 channel, 
for example, has been studied, as excessive activation of this channel is 
known to cause unbalanced calcium signalling in human effector T cells, 
leading to excessive activation and autoimmune disease (Beeton et al. 2006). 
Deletion or suppression of Kv1.1 (KCNA1) has been demonstrated to cause 
increased sensitivity to pain stimuli in studies conducted with mice, with Kv1.1 
null mutations also reduced the effectiveness of morphine and other opiates 
in relieving neuropathic pain (Galeotti et al. 1997, Clark and Tempel 1998). It 
has been suggested that absence of Kv1.1 may reduce the action potential 
required to activate sensory neurons, causing nerve cells to become 
hyperexcitable, potentially explaining the reduced effectiveness of 
anaesthetics in null mutants (Ishikawa et al. 1999). 
Localised application of the local ester-type anaesthetic butamben, a topical 
anaesthetic typically associated with rapid, but short-term suppression of pain, 
to the spinal column via epidural has been found to produce long-lasting relief 
for chronic pain with few side-effects (Beekwilder et al. 2003). An interaction 
16 
 
between butamben and Kv1.1 has been demonstrated, with inhibition of Kv1.1 
activity also reported. It is not clear however if reductions in analgesic 
responses are caused by inhibition of Kv1.1 by butamben, or through its 
interaction with other components involved in signal transmission in the dorsal 
root ganglion (Beekwilder et al. 2003). 
There are currently no known ligands which have been proven to bind and 
inhibit Kv1.1 with specificity over related voltage-gated channel activity. While 
some experimental evidence suggests that Kv1.1 is involved in the 
transmission of neuropathic pain, the details of its role in this process has also 
not been established with any certainty. Indeed, a recent study has suggested 
that the voltage-gated sodium channel Nav1.8, which has also been linked to 
neuropathic pain, is also inhibited by butamben (Garrison et al. 2014, Thériault 
and Chahine 2014). The development of structural insights of Kv1.1 inhibition 
may provide clues as to the significance of its role in pain management. 
1.4 Application of electron microscopy 
Electron microscopy (EM) possesses a number of advantages over the more 
traditionally popular technique of X-ray crystallography. First and foremost, 
EM require significantly smaller quantities of sample, in theory requiring only 
micrograms, rather than milligrams. This can remove significant hurdles to the 
determination of the structure, such as limitations in sample acquisition, low 
expression or less efficient purification, are less of an issue owing to the ability 
to positively select particles of specific shapes in electron micrographs. 
The analysis of proteins via EM is not limited by the ability of target molecules 
to for highly ordered crystals, rather its focus on individual particles in 
17 
 
suspension theoretically allows proteins to be observed in states more similar 
to their conformations in their conditions in free solutions. 
In recent years, EM has risen to become an essential tool in the investigation 
and analysis of biomolecular structures. While historically limited to large 
complexes or highly symmetrical structures, recent advances in technology 
have significantly improved the competitiveness of EM in the field. In recent 
years, the proportion of structures which have been determined by cryo-
electron microscopy (cryo-EM) has been steadily increasing as a proportion 
of published protein structures (Earl et al. 2017) (Protein Data Bank in Europe 
2018) (Figure 1.4). 
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Figure 1.4 – Graphs detailing the rise year-on-year of structures 
determined by electron microscopy vs. other methods (Protein Data 
Bank 2018, Protein Data Bank in Europe 2018). 
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The recent development of direct electron detectors (DEDs) have improved 
the signal to noise ratio and contrast of micrograph images, allowing 
structures attained by EM to reach atomic resolutions (Bai, X. chen et al. 
2015). Additionally, they allow movies to be captured at significantly higher 
framerates, reducing exposure times and, in turn, reducing radiation damage 
of samples. The higher number of recorded movie frames also permits 
improved motion correction of micrographs, allowing more precise averaging 
of microscope views, decreasing image blur and increasing particle resolution 
(Thompson, R. F. et al. 2016, Bai, X. chen et al. 2015). 
Membrane proteins have not been exempt from this renaissence in EM 
technology. In recent years, a number of high-profile membrane proteins have 
had their structures determined to atomic resolution through cryo-EM, 
including Ryanodine Receptor 1 (Ryr1), Piezo1, Gamma Secretase and 
Voltage-Gated Calcium Channel α-1 (Cav1.1) (Yan, Zhen et al. 2015, Ge et 
al. 2015, Lu, P. et al. 2014, Wu, J. et al. 2015). (Figure 1.5). 
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Figure 1.5 – Cartoon representation of a selection of membrane proteins whose structures have recently be determined through 
electron microscopy (Yan, Zhen et al. 2015, Ge et al. 2015, Lu, P. et al. 2014, Wu, J. et al. 2015).
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1.5 Aims and objectives 
This project was conceived with the aim of expressing and purifying the 
human variant of Kv1.1 for structural study, followed by investigation of the 
structural basis of its interactions with known inhibitors. This information could 
then be applied to the development of rationally designed drug molecules 
targeting Kv1.1, whose inhibition could then be exploited for pain relief. 
The above aim was planned to be achieved through obtaining the following 
objectives: 
• Design and construct plasmid to encode and express Kv1.1 with tags 
to assist purification and analysis 
• Develop mammal cell-based host systems for overexpressing the 
Kv1.1 ion channel complex 
• Purify the Kv1.1 complex using C-terminal tags to avoid disrupting 
residues at the N-terminal involved in membrane targeting 
• Investigate extraction by SMA and DIBMA nanodisc scaffolds and 
compare their effectiveness with traditional detergents 
• Determine the structure of the complete Kv1.1 channel alone and in 
complex with the regulatory Kvβ2 subunit through cryo-EM 
• Investigate the effects of various inhibitory molecules on the 
electrophysiological characteristics of the Kv1.1 pore 
• Establish the binding sites of inhibitor molecules at the Kv1.1 channel
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2 Materials and Methods 
2.1 Cloning strategy and construct design 
2.1.1 Expression vector design 
2.1.1.1 Use and advantages of pcDNA plasmids 
The cloning and expression of KCNA1 and KCNAB2 was mediated by 
pcDNA6 and pcDNA3.1 plasmids, respectively (see Appendix 8.1 for details), 
which possess a number of features making them appropriate for the needs 
of the project. Firstly, these plasmids are suitable for transformation into 
bacterial hosts for amplification and storage. To compliment this, pcDNA6 and 
pcDNA 3.1 both carry an ampicillin resistance gene, allowing transformed 
bacteria to be selected through the application of appropriate antibiotics 
(ampicillin, carbenicillin, etc.). pcDNA plasmids also possess a human 
cytomegalovirus (CMV) immediate-early promoter upstream of the plasmid 
polyclonal site, which enables inserted genes to be expressed in mammalian 
systems, such as HEK (human embryonic kidney) 293 cells.  
pcDNA plasmids carry additional genes encoding for resistance to antibiotics 
that target mammal cells. pcDNA6 and pcDNA3.1 carry resistance gene for 
blasticidin and neomycin, respectively allowing antibiotics to be used to select 
for transfected HEK 293 cells. This feature aids the development of stably 
transfected cell lineages through elimination of non-transfected cells. 
Additionally, as both plasmids contain resistance genes for different 
antibiotics, they can be selected for via separate antibiotics. Each gene 
inserted into these plasmids were accompanied by upstream Kozak 
consensus sequences to facilitate gene transcription in eukaryotic cells. 
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2.1.1.2 Fusion tags 
A number of tags were selected for inclusion in Kv1.1 and Kvβ2 fusion 
constructs. The addition of tags was used to modify the properties of the 
expressed proteins, allowing, approaches to expression and purification not 
available while working with native proteins. The fusion tags used during in 
constructs development are listed below in Table 2.1. 
2.1.1.3 Design of Kv1.1 constructs and cloning vectors 
Cloning and expression of the KCNA1 gene was mediated through the 
pcDNA6 plasmid. pcDNA6 plasmids encoding three Kv1.1 constructs were 
provided by Dr. Jon Lippiat of the University of Leeds School of Biomedical 
Sciences at the beginning of the project: 
• KCNA1 – Native Kv1.1 
• KCNA1-EYFP – Kv1.1 + C-terminal enhanced yellow fluorescence 
protein tag 
• KCNA1-V5-His6 – Kv1.1 + C-terminal V5 antibody epitope and 
hexahistidine tag 
These constructs formed the basis of further constructs, through modification 
of plasmids via site-directed mutagenesis. Kv1.1 constructs featuring 
additional and alternative tags were designed to allow multiple methods for 
purification to be tested. Tags were restricted to the C-terminal of the protein 
in order to reduce the risk of disruption of insertion of the N-terminal region of 
the protein into the cell membrane. Tobacco etch virus (TEV) protease 
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cleavage sites with the sequence ENLYFQS were also included upstream of 
some tags in some constructs to allow their removal following purification. 
Tag Function Amino acid sequence 
EYFP 
Indicator of protein expression 
through fluorescence 
chromatography. 
Target for anti-green fluorescent 
protein (GFP) antibodies in 
western blotting. 
Potential epitope for purification 
using anti-GFP antibody resin. 
VSKGEELFTGVVPILVELDGDVNGHKFS
VSGEGEGDATYGKLTLKFICTTGKLPVP
WPTLVTTFGYGLQCFARYPDHMKQHDFF
KSAMPEGYVQERTIFFKDDGNYKTRAEV
KFEGDTLVNRIELKGIDFKEDGNILGHK
LEYNYNSHNVYIMADKQKNGIKVNFKIR
HNIEDGSVQLADHYQQNTPIGDGPVLLP
DNHYLSYQSALSKDPNEKRDHMVLLEFV
TAAGITLGMDELYK 
V5 
Antibody epitope for purification 
on anti-V5 antibody resin and 
antibody target in western 
blotting. 
GKPIPNPLLGLDST 
c-Myc 
Antibody epitope for purification 
on anti-Myc antibody resin. 
EQKLISEEDL 
Hexa/deca-
histidine tag 
(His6/10) 
Nickel-cobalt-binding group used 
in immobilised metal affinity 
chromatography; extension to 
His10 increases metal affinity. 
Target for anti-polyhistidine 
antibodies in western blotting. 
HHHHHH[HHHH] 
FLAG 
Antibody epitope for purification 
on anti-FLAG antibody resin. 
DYKDDDDK 
 
Table 2.1 – Fusion tags utilised during Kv1.1 and Kvβ2 construct 
design and production. The function and amino acid sequences of each 
tag had been included in the table to provide context for their use.  
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The following constructs were planned for development during the course of 
the project: 
• Kv1.1-EYFP-His6 
• Kv1.1-TEV-EYFP-His6 
• Kv1.1-TEV-EYFP-His10 (Kv1.1-TY10) 
• Kv1.1-TEV-EYFP-His10-FLAG 
To this end, a series of primers were designed in order to modify the base 
Kv1.1-EYFP construct encoded in pcDNA6 in order to introduce new elements 
and remove unwanted ones (See Table 2.2). 
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Tags Forward primer Reverse primer Melting 
temp (°C) 
EYFP-His6 CATCATCACCATCACCATTGAGTTTAAACC CTTGTACAGCTCGTCCATGCC 58.1 
TEV-EYFP-His6 CTTCCAGAGCGTGAGCAAGGGCGAGGAG TACAGGTTCTCGAATTCAACATCGGTCAGTAGC 58.5 
TEV-EYFP-His10 CACCATCACCACCATCATCACCATCACCATTGAGTT
TAAACCCGCTGATC 
GGATCACTCTCGGCATGGACGAGCTGTACAAG 63.8 
TEV-EYFP-His10-FLAG GATGATGACAAGTGAGTTTAAACCCGCTGATCAGCC
TCGACTGTGC 
GTCCTTGTAGTCATGGTGATGGTGATGATGGTGATG
ATGGTGCTTGTACA 
62.7 
 
Table 2.2 – Primers used in the modification of plasmids encoding Kv1.1-EYFP constructs. The elements encoding for various 
elements have been colour coded, with EYFP in yellow, Polyhistidine in green, TEV in red and FLAG in blue. The melting 
temperature refers to the temperature the elements which anneal to the unmodified plasmid (in capitals) denature.
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The KCNA-EYFP-His6 construct was developed by modifying the plasmid 
encoding the KCNA1-EYFP construct. This was achieved through insertion 
and deletion through PCR (see section 2.1.2 for details on PCR method) (Lee, 
J. et al. 2010). using a forward primer to clone outward from the His6 segment 
of the pcDNA6 plasmids and a reverse primer above designed to anneal and 
clone outward from 3’ end of the gene encoding Kv1.1-EYFP, while excluding 
the stop codon. 
>KCNA1Gb_His_forward 
5’-catcatcaccatcaccattgagtttaaacc-3’ 
>KCNA1Gb_His_reverse 
5’-cttgtacagctcgtccatgcc-3’ 
The above primers excluded both the stop codon and linker between the 
KCNA1-EYFP gene and the His6 encoding segment. This would produce a 
new gene with a polyhistidine tag fused onto the C-terminal end of the product. 
Sequencing of the resulting plasmid was carried out to check that the PCR 
program had produced the desired mutations. Once the plasmid encoding the 
KCNA1-EYFP-His6 fusion construct was available, this plasmid was in turn 
used as the basis for the development of a Kv1.1-TEV-EYFP-His6 fusion 
construct. Production of this plasmid was carried out through further PCR 
mutagenesis, using the following forward and reverse primers: 
>KCNA1G_His_TEV_forward 
cttccagagcgtgagcaagggcgaggag 
>KCNA1G_His_TEV_reverse 
tacaggttctcgaattcaacatcggtcagtagc 
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The Kv1.1-TEV-EYFP-His6 plasmid was further modified to produce a Kv1.1-
TY10 construct. This was undertaken using the following forward and reverse 
primers, which were designed to add four additional histidine codons to the C-
terminal of the fusion protein, with the additional histidine codons highlighted 
in green: 
>KCNAB2-His10_Forward 
catcatcaccatcatcaccatcaccattgagtttaaacccgctgatcag 
>KCNA1-His10_Reverse 
gtgcttgtacagctcgtccatgccgagagtgatccc 
2.1.1.4 Design of Kvβ2 constructs and cloning vectors 
Kvβ2 expression and cloning was mediated through the use of pcDNA3.1 
plasmids. pcDNA3.1 was selected as the vector for KCNAB2 as it features a 
neomycin resistance gene in place of blasticidin resistance gene. This allowed 
for selection of cell lines co-transfected with both pcDNA6 and pcDNA3.1. As 
Kvβ2 is a soluble protein, fusion tagging of the N-terminal was considered to 
be less of a risk to protein folding and stability, as intracellular soluble proteins 
typically possess fewer signal peptides compared to membrane proteins and 
secretary proteins. 
The KCNAB2 gene was sourced from foetal human brain cDNA library. 
Designs for Kvβ2 constructs included eliminating the stop codon at the 3’ end 
of KCNAB2, allowing transcription to run through the full length of the gene 
into downstream hexahistidine and c-Myc tags encoded by the pcDNA3.1 
plasmid, terminating with an included stop codon. as well as the addition of a 
fluorescent mCherry tag to allow Kvβ2 to be detected separately from EYFP-
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tagged Kv1.1 in doubly transfected cell lines. Primers were designed to 
facilitate these goals (Table 2.3).
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Tags Forward primer Reverse primer Melting 
temp (°C) 
Foetal cDNA GCCGGAATTCACCATGTATCCAGAATCAACGAC
GGGCTC 
GCGGTCTAGATTAGGATCTGTAGTCCTTTTTGC
TGTAGGGTTTATTG 
64.6 
cMyc-His6 CCCGCGGTTGAACAAAAACTCATCTCAGAAGAG
GATCTGAATATGC 
CCCTCTAGAGGATCTGTAGTCCTTTTTGCTGTA
GGGTTTATTGCCC 
66.4 
His6-mCherry GTCTAGAGTTTCAAAAGGTGAAGAAGATAATAT
GGCTATTATTAAAG 
GACCGGTTTTATATAATTCATCCATACCACCAG
TTGAATGTCTACC 
59.2 
 
Table 2.3 – Primers used in the modification of plasmids encoding Kvβ2 constructs.
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A pcDNA plasmid encoding native KCNAB2 protein was generated through 
PCR cloning from a human cDNA library derived from foetal human brain 
cells. Primers for the cloning of human KCNAB2 were designed based on the 
sequence of the Homo sapiens variant with NCBI reference code 
NM_003636.3:  
>KCNAB2_forward_primer 
GCCGGAATTCACCATGTATCCAGAATCAACGACGGGCTC 
 
>KCNAB2_reverse_primer 
GCGGTCTAGATTAGGATCTGTAGTCCTTTTTGCTGTAGGGTTTATTG 
 
The primers above were designed to allow restriction digestion and ligation 
into the pcDNA3.1 plasmid. The elements highlighted in red in the primer 
sequences denote these restriction sites (EcoRI in the forward primer, XbaI in 
the reverse primer). The PCR product was then subjected to restriction 
digestion by EcoRI and XbaI and ligated into a pcDNA3.1 plasmid cut with the 
same restriction enzymes and the KCNAB2 gene was ligated into the cut 
pcDNA3.1 plasmid. Modification of the plasmid was checked through 
sequencing. 
A further KCNAB2 construct was generated featuring a 3’ region encoding for 
a C-terminal c-Myc-His6 tag through PCR mutagenesis. This was undertaken 
using forward and reverse primers designed to remove the stop codon at the 
end of the KCNAB2 gene, allowing the c-Myc and His6 tags downstream of 
EcoRI 
XbaI 
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the polyclonal site to be transcribed with the gene. The primers used had the 
following sequences: 
>KCNAB2-Stop_Forward 
cccgcggttgaacaaaaactcatctcagaagaggatctgaatatgc 
>KCNAB2-Stop_Reverse 
ccctctagaggatctgtagtcctttttgctgtagggtttattgccc 
2.1.2 PCR 
2.1.2.1 Site-directed mutagenesis 
Site-directed mutagenesis was utilised during the course of the project to 
modify the nucleic acid sequence of plasmids. This allowed the amino acid 
sequences of final expressed proteins to be adjusted to include or exclude 
linking segments or to add or remove fusion tags. Site-direct mutagenesis was 
performed using custom forward and reverse primers designed to hybridise to 
loci within plasmids where modifications were desired. Modifications were 
designed to introduce new nucleotide sequences, exclude sections of the 
template to delete unwanted segments, or modify sequences. 
Polymerase chain reactions were carried out using Q5 polymerase (New 
England Bioscience). Reactions were carried out in both 25 μl and 50 µl 
volumes, depending on the need for product DNA. 0.5 µM forward and reverse 
primers were applied, along with appropriately dilute 5 × Q5 polymerase 
reaction buffer (New England Bioscience) and 200 µM dNTPs. The volumes 
of each component used in reaction mixtures is detailed in Table 2.4. 0.5 μg 
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of template plasmid DNA was added and the volume of the reaction mixtures 
increased to the addition of nuclease-free triple-distilled water. 
 
Forward primer   
(10 µM) 
Reverse primer    
(10 µM) 
Q5 reaction 
buffer 
dNTPs 
(10 mM) 
25 µl vol. 1.25 µl 1.25 µl 5 µl 0.5 µl 
50 µl vol. 2.5 µl 2.5 µl 10 µl 1 µl 
 
Table 2.4 – Table detailing the mixture of primers, buffers and reagents 
used in the standard PCR protocol used in the course of the project. 
Touchdown PCR was then used to generate and amplify the mutagenized 
plasmid. This was conducted using a Dyad DNA Engine thermal cycler (Bio-
Rad).  The programme involved an initial 1 min melt at 98C before the thermal 
cycle. Each subsequence cycle was programmed to begin with a 30 sec 
melting step at 98C, followed by a 30 sec annealing step, which varied 
between each cycle, followed by a final extension step at 72C for 20 sec. The 
annealing step was programmed to begin at 5 C above the primers’ melting 
temperature in the first cycle, reducing in 0.5C increments for 19 cycles to 
5C below the primers’ melting temperature. This was followed by 10 further 
cycles with an annealing at 5C below the primers’ melting temperature for a 
final total of 30 cycles (see Table 2.1 for the melting temperatures of primers 
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used). The programme then concluded with a final extension at 72C for 3 
min, before reducing to holding temperature of 10C for recovery. 
Following PCR amplification, reaction mixtures were treated with DpnI 
restriction enzyme, which has a short recognition site, GATC, and only 
recognises methylated DNA. DpnI treatment digested and eliminated 
methylated template plasmid derived from bacterial cultures, leaving only the 
PCR product. These reaction mixtures were then loaded and run on 1% 
agarose gels (see section 2.1.5), with any bands corresponding to the 
predicted weight of the desired PCR product recovered through gel extraction 
using a QIAquick gel extraction kit (Qiagen) following the manufacturer’s 
instructions.  
The process of site-directed mutagenesis was used extensively during the 
project in order to modify plasmids and generate new Kv1.1 fusion construct 
genes. For example, site-direct mutagenesis was used in order to insert 4 
additional histidine codons (CAC, CAG) onto the hexahistidine tag of the 
Kv1.1-TEV-EYFP-His6 construct in order to produce an extended 
dexahistidine tag, producing the Kv1.1-TY10 construct (see Table 2.1). 
2.1.2.2 Cloning from cDNA library 
Human KCNAB2 was cloned from a cDNA library derived from foetal brain 
tissue using PCR, with primers designed to hybridise with the 5’ and 3’ ends 
of the sequence encoding the protein. The primers (discussed in section 2.1.1) 
were designed to introduce an EcoRI restriction site at the 5’ end of the gene, 
along with a 3’ XbaI restriction site. 
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2.1.3 DNA fragment insertion 
2.1.3.1 Overhang restriction and ligation 
Extraction of segments of DNA and insertion into new vectors was sometimes 
handled through cutting of strands using specific restriction enzymes. Many 
restriction enzymes target specific palindromic sequences, creating single-
stranded overhangs which are able to hybridise with complementary 
sequences. DNA which has been cut with the same restriction enzymes will 
be able to hybridise, allowing the sequence to be ligated together. This can 
be exploited to excise segments flanked by restriction sites out of one DNA 
strand and insert it into a new vector which has been cut with the same 
restriction enzymes. 
DNA restrictions carried out during the course of this project were cut using 
enzymes supplied by New England Biosciences. 1 unit of enzyme is 
determined by the manufacturer as the amount of enzyme required to digest 
1 µg of Phage λ DNA in 1 hour at 37°C in a total reaction volume of 50 µl, with 
enzymes supplied at a concentration of 2 units/µl. Digestions were carried out 
by mixing 0.5 µl of restriction enzyme in supplier storage buffer for every µl of 
DNA in the reaction volume. CutSmart Buffer (New England Bioscience) was 
added to the reaction mixture at a ratio of 1:9, if compatible with the desired 
enzyme. If the restriction enzymes used were not compatible with CutSmart, 
NEBuffers 1.1, 2.1 or 3.1 were applied as appropriate instead. 
Reactions were placed into 37 C heating blocks for 1 hr incubation. DNA from 
the reaction was then visualised via agarose gel electrophoresis (See section 
2.1.5 for details). 
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2.1.3.2 CloneJET PCR cloning and blunt ligation 
PCR cloning and insertion into pJET1.2 was used in the extraction and 
amplification of the human KCNAB2 gene from foetal human brain cDNA (see 
Appendix 8.1 for details of plasmid). This method was used in order to reduce 
the number of steps required to generate a vector hosting the gene. Inserting 
the gene into pJET1.2 vector was selected as it would avoid an additional 
restriction digest step involved in sticky end-based ligation. Following 
insertion, it would also provide a series of restriction sites both upstream and 
downstream of the gene without potentially cutting any segments out of the 
polyclonal site. 
2.1.4 Bacterial culture 
2.1.4.1 Heat shock transformation 
Transformation of plasmids into bacterial hosts was used in order to clone and 
maintain populations of plasmid DNA. Transformations were conducted using 
XL1-Blue supercompetent E. coli cells (Aligent Technologies). This was 
carried out through incubation of 25 μl of competent cell stocks (containing ~ 
2.5 × 106 cells) on ice with 10 ng of plasmid DNA for 1 hr. Cells were then 
transferred to a 42°C heating block for 45 sec, then returned to ice and 
incubated for a further 2 min. Transformed cells were then taken forward to 
culturing on lysogeny broth (LB) agar plates. 
2.1.4.2 LB agar culture 
LB agar was produced from commercial powder (Sigma-Aldrich) and melted 
in doubly distilled water through heating to 120°C. Molten agar was split into 
37 
 
50 ml aliquots and allowed to cool to ~50°C. To select for transformed cells, 
50 μl of 100 mg/ml ampicillin solution was added to each agar aliquot for a 
final working solution of 100 μg/ml. 25 ml of molten agar was then poured into 
sterile 60 mm plastic petri dishes and allowed to cool until solid. 
Transformed XL1-Blue cells were transferred to agar plates and spread 
across the gel surface using a glass spreader under aseptic conditions. 
Inoculated plates were then placed into 37°C incubators and allowed to grow 
overnight. Following incubation, plates were retrieved and used in the 
inoculation of liquid LB cultures. Between uses, plates were sealed using 
parafilm wax; this was done to reduce infection and drying of the agar while in 
storage, extending the lifetime of the plates. 
2.1.4.3 Liquid LB culture 
Liquid LB was produced from commercial powder (Sigma-Aldrich). As with LB 
agar cultures, 100 mg/ml ampicillin solution was diluted ×1000 into Liquid LB 
to select for cells transformed with plasmid. Small-scale liquid cultures were 
established in 30 ml universal tubes containing 4 ml of Liquid LB. Discrete 
colonies identified on LB agar plates were collected using a wire loop and 
transferred to the 4 ml Liquid LB under aseptic conditions. Universal tubes 
containing inoculated medium were then placed into incubation at 37°C 
overnight on a 200 rpm shaker platform. Incubated media was collected 
following overnight incubation and cells were pelleted through centrifugation 
at 4,800 × g. The supernatant was then deposed through decanting and the 
pelleted cells placed into storage a -20°C for miniprep plasmid recovery at a 
later date. 
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Larger scale 500 ml Liquid LB culture volumes were also established in order 
to provide larger quantities of DNA for polyethylenimine  (PEI)-based HEK 293 
cell transfection carried out at later stages of work. These larger scale cultures 
were established through the inoculation of 500 ml Liquid LB with 0.5 ml of 
inoculated media from small scale cultures following overnight incubation. 
Cells were collected, pelleted and stored in the same manner as small-scale 
cultures. 
2.1.5 Agarose gel electrophoresis 
1% (w/v) agarose gels were made by mixing 500 mg agarose powder with 50 
ml TAE buffer. The powder was dissolved at high temperature through 
microwaving the mixture. Once the powder was melted, 1 µl ethidium bromide 
was added to the mixture and the molten gel poured into a mould with the 
appropriate comb added for the number of wells needed. 
Once cooled and solidified, the comb was gently removed and the gel was 
placed into a gel running system and submerged under a shallow pool of TAE 
buffer. Samples mixed with appropriately diluted gel DNA dye, purple (New 
England Bioscience) were then loaded into the wells, along with an 
appropriate DNA ladder for measuring the mass of species on the gel. 80 V 
was then applied across the gel for 60 min, with the gel loading wells placed 
adjacent to the negative anode. 
2.1.6 DNA sequencing 
Sanger sequencing of plasmid DNA was conducted externally by submission 
of samples to Source Bioscience and Beckman-Coulter (now GeneWiz).  
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Plasmids were sequenced using T7 forward and BGHR/BGHR2 reverse 
primers provided by the sequencing companies. Sequencing data was aligned 
with plasmid sequences using Clustal Omega, then evaluated and adjusted 
using Jalview 2 and SerialCloner 2.6.1 (Waterhouse et al. 2009, Sievers et al. 
2011). 
2.2 Protein expression 
2.2.1 Adherent human embryonic kidney cell culture 
Expression plasmids encoding Kv1.1 and Kvβ2 constructs were initially 
conducted in HEK 293 (Human Embryonic Kidney) TSA (tumour-specific 
antigen) cells. Stocks of HEK 293 TSA cells were maintained as adherent 
cultures in T25 tissue culture flasks. Cells were grown in Dulbecco’s modified 
Eagle’s/essential medium (DMEM) with high glucose + GlutaMAX™ 
supplement (Gibco; Life Technologies), mixed with 10% foetal bovine serum 
(FBS).  Cell cultures were grown at an ambient temperature of 37°C with 5% 
concentration of atmospheric CO2. 
Culture flasks were maintained until either the confluence of adhered cells 
reached ~80% or the pH indicator of the medium indicated significant 
acidification of the environment. Cells in these flasks were preserved through 
subculturing; this involved the removal of old media through aspiration, 
followed by washing of cells with 2 flask volumes of Dulbecco’s phosphate-
buffered saline (DPBS). Cells were then treated with 0.05% trypsin-EDTA 
(Gibco; Life Technologies); 200 µl for T25 flasks or 600 µl for T75 flasks. Cells 
were then incubated for 10-15 min at 37%. Following this, cells were dislodged 
by gentle aspiration of DMEM supplemented with 10% FBS to inhibit trypsin 
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enzymes and prevent damage to the cell by excessive proteolysis of 
membrane proteins. Resuspended cells were then transferred to a 15 ml 
falcon tube and pelleted through centrifugation at 200 x g for 3-5 min. The 
pelleted cells were then resuspended into a culture volume of DMEM, before 
being split and transferred a new flask and diluted × 10 in DMEM. Finally, the 
cells were placed back into incubation at 37°C. 
The size of the flask used varied in accordance with the total volume of the 
culture; T25 flasks were used for smaller-scale 5 ml cultures, T75 flasks were 
used for medium-scale 12 ml cultures and T175 flasks were used for large-
scale 30 ml cultures. 
2.2.2 Suspension HEK cell culture 
Culture of HEK cells in suspension was conducted using a protocol suggested 
by Dr. Paul Miller at Ludwig institute of Cancer, University of Oxford. HEK cells 
were transferred from adherent culture to suspension through trypsin 
treatment, followed by gentle detachment from flask surfaces by aspiration of 
medium. Dislodged cells were then deposited into 250 ml Erlenmeyer flasks 
containing 80 ml of FreeStyle (ThermoFisher Scientific) medium. Flasks were 
then placed into shaking incubators with an ambient temperature of 37°C, 8% 
atmospheric concentration CO2 with platform shaking rate of 120 rpm. 
For comparison of culture medium on cell growth rates, cultures were 
established from stably transfected Kv1.1-TY10-expressing HEK293S GnTI- 
cells gathered from adherent culture via trysinisation at 80% confluence. 
Establishment cultures were prepared in two 250 ml plastic Erlenmeyer flasks. 
Cells were seeded into 90 ml of medium, with several of media types (DMEM, 
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FreeStyle 293, Protein Expression Medium [PEM; ThermoFisher] and EX-
CELL [Sigma-Aldrich])  tested to compare their relative ability to sustain cell 
population growth. Media was supplemented with 100-fold diluted NEAA 
amino acid stock (Gibco), 100-fold dilute L-glutamine (Gibco), 100 mg/ml 
penicillin/streptomycin and 1% (v/v) foetal bovine serum (FBS) and topped up 
to a volume of 90 ml with either medium. 
The growth rates of cells were monitored daily using a Countess automated 
haemocytometer (Invitrogen). Once the density of cells had reached between 
2 and 3×106 cells per ml, cultures were split into two 40 ml volumes and diluted 
1:3 into 120 ml PEM for a final volume of 160 ml in 500 ml tissue culture grade 
Erlenmeyer flasks. Cells were then placed back into incubation under the 
same conditions as previously and incubated until the cell density again 
approached 3×106 cells per ml. Once this density was reach, 5 mM sodium 
butyrate was added to the cell medium to boost protein expression (Kruh 
1981). Cells were then collected through pelleting out of the medium by 
centrifugation at 200  g. 
In parallel to this, as there was no previous in-house experience with 
suspension HEK cell culture, experimentation was conducted with a series of 
media types was to identify the most effective type for maintain viable cells at 
a high rate of growth. For this, adherent HEK cells were seeded into 80 ml 
FreeStyle 293, PEM, EX-CELL and Gibco DMEM (Thermo Fisher) in 250 ml 
tissue culture grade Erlenmeyer flasks and their growth (living cell count) and 
viability (% living cells/total cell count) were recorded every 24 hrs. 
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2.2.3 Transient human embryonic kidney cell transfection 
2.2.3.1 FuGENE-mediated cell transfection 
Transfection of HEK cells via FuGENE HD transfection reagent (Promega) 
was carried for transfection of small-scale T25 flask cultures. 5 μl of FuGENE 
HD reagent was mixed into 100 μl of OptiMEM (Gibco; Life Technologies). 2 
μg of plasmid DNA was then added and the mixture was allowed to incubate 
for 20 min at room temperature. The incubated solution was mixed into flasks 
containing freshly seeded HEK cells at ~25% confluence. 24 hrs after the 
addition of the transfection reagent, 5 mM sodium butyrate was applied to the 
transfected cell to boost protein expression. After a further 24 hrs, the 
transfected cells were collected through removal of media via aspiration, 
followed by 2 × wash with DPBS. Cells were then gently dislodged through 15 
min incubation in DPBS at 37°C and pelleted through centrifugation at 200 × 
g and the supernatant discarded via decanting. 
2.2.3.2 PEI-mediated transfection 
Cells were seeded in Gibco DMEM + 10% foetal bovine serum (FBS) and 1% 
penicillin-streptomycin at a confluence of 25% (for seeding density see Table 
2) one day prior to transfection. Cells were then allowed to adhere overnight 
at 37°C and 5% ambient atmospheric concentration of CO2 prior to 
transfection, the flask media was removed via aspiration and replaced with 
DMEM + 5% FBS and 1% penicillin-streptomycin (Table 2.5) and the 
flask/plate returned to 37°C, 5% atmospheric CO2 for 1 hr. 
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Flask/Plate Volume of DMEM + 5% FBS 
media applied 1 hr prior to 
transformation 
96 well 100µl 
24 well 400µl 
6 well 2ml 
35 mm 2ml 
T25 2ml 
T75 6ml 
 
Table 2.5 – Volume of media used in adherent HEK 293 cells one hour 
pre-transfection. 
DNA-PEI complexes were prepared in advance through mixing at a ratio of 
5:2, DNA:PEI. The volumes of DNA (400 µg/ml) and PEI (1 mg/ml) used in 
flasks of different volumes is detailed in Table 2.5. PEI was added to the 
desired plasmid DNA and mixed by swirling with a pipette tip and the mixture 
was allowed to incubate at room temperature for 10 minutes. DMEM + 5% 
FBS and 1% penicillin/streptomycin was then added to the DNA-PEI complex 
(see Table 2.6 for amount) and mixed by aspiration. The whole solution was 
subsequently added to the flask/plate and mixed by gentle rocking. 
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 96 
well 
24 well 6 well 35 mm T25 T75 
DNA, 400 µg/ml (µl) 0.83 5.20 25 20.8 65 195 
PEI, 1 mg/ml (µl) 0.33 2.08 10 8.33 26 77.5 
DMEM + 5% FBS (µl) 3.33 20.79 100 83.3 260 777.5 
Total volume (µl) 4.49 28.07 135 112.5 351 1050 
 
Table 2.6 – Table describing PEI:DNA complex formulation for wells 
and plates of varying sizes. 
 
Flasks/plates were then returned to the incubator and left at 37°C with 5% 
CO2 for 24 hours. The media was then removed via aspiration and replaced 
with DMEM + 10% FBS and 1% penicillin/streptomycin (in the same volume 
as detailed in Table 2.6). 5 mM sodium butyrate was then applied to increase 
protein expression. The flasks/plates were to incubator and left at 37°C with 
5% CO2 overnight; the cells were harvested 48 hrs after transfection. 
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2.2.4 Development of stably transfected HEK 293S GnTI- cell lines for 
Kv1.1 expression 
Stably transfected HEK 293S cell lineages were established to reduce the 
need to generate the large volumes of plasmid required for PEI-based 
transfection, requiring large investments in time and resources, or expensive 
FuGENE-based methods. Stably transfected cell lineages were also better 
suited to larger scale cell cultures, as scales beyond T75 flasks would require 
generating volumes of plasmid DNA difficult to realistically achieve. 
HEK 293S GnTI- cells were selected as host for stable transfection, as their 
adaptability to larger-scale suspension culture would allow scaling of 
expression cultures to larger volumes in the event that smaller-scale 
expression and purification trials proved encouraging. 
Stably transfected cells were generated through transfection of cells in a T25 
using the FuGENE HD reagent method detailed above (see section 2.2.3). 
Once cells had developed to ~80% confluence, the medium was removed 
through aspiration and the cells washed twice with 5 ml DPBS. Cells were 
then treated with 200 µl of 0.05% Trypsin-EDTA (Gibco) and incubated at 
37°C for approximately 10 min. After this, cells were then dislodged with 5 ml 
DMEM:F12 media and pelleted gently through centrifugation at 200 ×g for ~10 
min. The supernatant was then removed through decanting and the cells 
resuspended in 5 ml of fresh DMEM:F12 medium. Plates were placed into a 
37°C incubator with a 5% ambient atmospheric CO2 concentration for 
culturing. 
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2.2.5 Fluorescence microscopy 
Observation of fluorescence linked to EYFP tags attached to Kv1.1 constructs 
was used to quickly assess expression of transfected cells. Fluorescence was 
observed using a Nikon Eclipse TE2000-U inverted microscope in conjuncture 
with a Nikon C-SHG1 Super High-Pressure Mercury Lamp Power Supply. The 
lamp output light was filtered with an excitation filter, allowing only light around 
the wavelength of 475 nm (±5 nm), which corresponds to a major excitation 
wavelength of EGFP and a minor excitation wavelength of EYFP, to pass 
through. Emission wavelengths were observed through a green light filter. 
Photographs of the microscope viewing field were taken using a Si-3000 
digital camera (CETI). 
2.3 Protein purification 
2.3.1 HEK cell lysis 
2.3.1.1 Tissue grinding cell homogenisation 
Cells were resuspended in 1 ml of lysis buffer (50 mM Tris pH 7.6, 300 mM 
NaCl and Roche cOmplete EDTA-free protease inhibitor cocktail tablet [1 
tablet dissolved per 50 ml of buffer]) and transferred into a 35 ml Potter-
Elvehjem tissue grinder mortar. Cells were disrupted on ice with 25 gentle 
motions of the tissue grinder pestle. Lysate was then recovered via aspiration. 
2.3.1.2 Sonication 
HEK293 cells were then resuspended in 500 μl lysis buffer (50 mM Tris pH 
7.5, 300 mM NaCl and Roche cOmplete protease inhibitor cocktail tablet) and 
transferred to a microcentrifuge tube and placed on ice. Sonication was 
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conducted using a Vibra-Cell VCX 130 processor (Sonics & Materials). The 
sonicator probe was inserted into the tube, with attention paid to ensure that 
the tip of the probe had been lowered beneath the lysis buffer surface and out 
of contact with the walls of the tube. The probe was steadied by a stand-and-
clamp to ensure that it remained stationary after set-up. Sonication of HEK 
cells was carried out at amplitude 40. Sonication was applied as a series 4 × 
5 sec bursts, separated by 3 × 25 sec cool-down periods on ice. 
2.3.1.3 Direct dissolve in detergent 
Pelleted HEK293 cells were dissolved directly in lysis buffer (50 mM Tris pH 
7.5, 300 mM NaCl and Roche cOmplete protease inhibitor cocktail tablet) 
supplemented with 1% (w/v) DDM. The cell/lysis buffer mixture was placed on 
a rolling platform for gentle agitation for 2 hrs in a refrigerated cold room 4 °C. 
2.3.2 Membrane protein extraction 
2.3.2.1 Solubilisation in detergent 
Following cell lysis, raw lysate fractions were separated via centrifugation for 
60 min at 17,000 × g. The soluble fraction supernatant was separated from 
the pelleted insoluble fraction through aspiration. The insoluble fraction was 
then resuspended in lysis buffer (see section 4.6.1) with 0.1% detergent based 
on standard lab protocols used by the Muench Group and allowed to dissolve 
for 2 hrs on a rolling platform at 4°C. Initially, detergent solubilisation by SDS 
and DDM were compared to identify which of the two would provide the 
greatest yields for early protein purification trials. The detergent-solublilised 
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lysate was then centrifuged again to remove any remaining insoluble debris 
and the supernatant was collected for purification trials. 
2.3.2.2 Solubilisation in amphipathic maleic acid polymers 
Solubilisation of membrane proteins in SMA and DIBMA was undertaken 
though whole-cell dissolving of HEK cells. 2.5% (w/v) SMA or DIBMA polymer 
were dissolved in 300 mM NaCl, 10 mM KCl, 50 mM Tris and and Roche 
cOmplete EDTA-free protease inhibitor cocktail tablet at pH 7.4; this solution 
was then applied to pelleted cells in a 1:1 ratio of cell weight to buffer volume. 
The cells were dissolved for 1 hr at room temperature on a rotating platform 
or overnight at 4°C (the timescale was extended for lower temperature 
solubilisation as the lipids of the membrane are less fluid at lower 
temperatures). Following solubilisation, the mixture was gently homogenised 
on using a Potter-Elvehjem tissue grinder mortar to break up any large 
fragments remaining in solution. 
2.3.3 Immobilised metal affinity chromatography 
2.3.3.1 Batch purification 
Initial trials were conducted using cobalt-charged TALON metal affinity resin 
(GE healthcare). These early trials were conducted using the batch 
purification method, which allowed purification trials to be conducted faster 
than using the column method. Later purification trials utilised HisPur cobalt 
resin (Thermo Fisher Scientific), as it was found to be as effective as TALON 
resin while being significantly less expensive. 
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Batch purifications were set up by gently resuspending the metal affinity resin 
(HisPur or TALON) through gentle agitation on rolling platform. 50 µl of resin 
was then transferred into a 1.5 ml microcentrifuge tube and washed with 900 
µl triple-distilled water and the tube centrifuged at 800 × g for 2 min in 
benchtop microfuge. The supernatant was carefully removed via aspiration 
and the pelleted resin was washed two additional times with 1 ml of triple-
distilled water to remove any remaining storage buffer. 
Following washing, the resin was mixed with detergent dissolved insoluble cell 
lysate (25 µl of pre-incubation detergent-solublised lysate was retained for 
SDS-PAGE analysis). The resin and cell lysate were then mixed with 150 µl 
equilibration buffer (×1 Tris-buffered saline [TBS], 3 mM imidazole, 0.1% 
DDM) and was then incubated on a rolling platform at 4°C for 1 hr. The mixture 
was subsequently pelleted in a benchtop microfuge at 800 rpm for 2 min and 
the supernatant removed through aspiration, with 25 μl of the supernatant 
retained for SDS-PAGE analysis. The resin was then washed twice with 500 
µl equilibration buffer, followed by two further washes in 500 µl wash buffer 
(×1 TBS, 30 mM imidazole, 0.05% DDM); the supernatant from the first wash 
buffer rinse was retained for SDS-PAGE analysis. Finally, 120 μl of elution 
buffer (×1 TBS, 300 mM imidazole, 0.05% DDM) was applied to the resin and 
allowed to incubate on rolling platform at 4°C for 5 min. The resin was then 
pelleted through a final centrifugation at 800 × g and the supernatant 
recovered via aspiration. Both the elution fraction and pelleted resin were 
retained for SDS-PAGE. 
50 
 
2.3.3.2 Gravity column 
IMAC purification via gravity column was conducted using HisPur cobalt resin. 
Columns were prepared by transferring 2 × desired column volume of 1:1 
HisPur resin slurry into a 5 ml or 15 ml disposable plastic column, depending 
on the volume of resin used, with a porous filter to allow passage of fluids 
while holding the resin in place. IMAC purifications were performed at 4°C in 
a temperature-controlled environment, with all buffers chilled to 4°C in 
advance.  The resin was allowed to settle before the 20% ethanol holding 
buffer was drained away under gravity. 
The resin was then primed with 2 × column volumes of Equilibration Buffer 
(150 mM NaCl, 10 mM KCl, 50 mM Tris, 10 mM imidazole pH 7.6 + Roche 
cOmplete EDTA-free protease inhibitor, 0.1% DDM), which was allowed to 
drain immediately off of the column. The lysis solution containing the protein 
was then applied to the column and allowed to incubate for 10-15 min. The 
lysis mix was then drained away via gravity and collected for visualisation via 
SDS-PAGE later. The column was then washed with 2 further column volumes 
of Equilibration Buffer, which were allowed to drain away immediately under 
gravity. 
The column was then washed with 12 × column volumes of Wash Buffer (150 
mM NaCl, 10 mM KCl, 50 mM Tris, 30 mM imidazole pH 7.6 + Roche 
cOmplete EDTA-free protease inhibitor, 0.1% DDM). The higher imidazole 
content of the wash buffer was used to wash away weakly interacting 
contaminants which would associate with the resin. The Wash Buffer was 
allowed to incubate for 15 minutes before being eluted and retained for SDS-
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PAGE. This was followed by a 12 × column volume wash with Elution Buffer 
1 (150 mM NaCl, 10 mM KCl, 50 mM Tris, 100 mM imidazole pH 7.6 + Roche 
cOmplete EDTA-free protease inhibitor, 0.05% DDM) and allowed to incubate 
for 15 minutes, before being eluted and stored for SDS-PAGE. Finally, 12 × 
column volumes of Elution Buffer 2 (150 mM NaCl, 10 mM KCl, 50 mM Tris, 
250 mM imidazole pH 7.6 + Roche cOmplete EDTA-free protease inhibitor, 
0.05% DDM) was applied to the resin and allowed to incubate for 15 minutes 
before elution and storage for SDS-PAGE. 
It should be noted that for purification of DDM-solubilised protein, the 
Equilibration, Wash, Elution 1 and Elution 2 buffers were supplemented with 
0.1% (w/v), 0.05% (w/v), 0.02% (w/v) and 0.02% (w/v) DDM respectively in 
order to gradually reduce detergent concentration to values close as possible 
to the CMC of DDM in solution with NaCl (~0.012% [w/v]) to reduce 
interference by the detergent during later steps (Generon Ltd n.d.). 
2.3.3.3 HisTRAP column 
IMAC purification on a 1 ml HisTRAP HP column (GE Healthcare) charged 
with cobalt ions was conducted on an Äkta Explorer pump system (GE 
Healthcare). Purification was conducted in a temperature controlled cabinet 
maintained at a constant temperature of 4°C. Prior to sample injection, the 
system was washed with 10 column volumes of IMAC Buffer A (150 mM NaCl, 
10 mM Tris pH 7.6, 10 mM KCl, 0.02% DDM). Once injected, the column was 
washed with 5 ml of IMAC Buffer A. After the initial 5ml wash with IMAC Buffer 
A, IMAC Buffer B (150 mM NaCl, 10 mM Tris pH 7.6, 10 mM KCl, 300 mM 
imidazole, 0.02% DDM) was gradually exchanged into the mash mixture at a 
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rate of 5% per ml. Elution fractions from the Äkta were then collected in 
batches of 150 µl. 
2.3.4 Size-exclusion chromatography purification 
Size-exclusion chromatography (SEC) was employed as a secondary 
purification step following IMAC. Purification was conducted in a temperature-
controlled cabinet maintained at a constant temperature of 4°C SEC 
purification was conducted using an Äkta Explorer pump system, with sample 
applied to Superdex 200 column (GE Healthcare). Samples were injected into 
the system through 50 µl or 100 µl sample loop, with the loop size chosen 
appropriate for the bed volume of resin used. 
2.3.5 TEV cleavage 
TEV cleavage was conducted using the ProTEV enzyme kit (ProMega). 
Reactions were conducted by following the protocol specified by the 
manufacturer: 20 µl of Kv1.1-TY10 at an estimated concentration of 0.5 mg/ml 
was mixed with 5 µl of 20 ProTEV buffer supplied by the manufacturer, 1 µl 
of 100 mM DDT and 10 units of ProTEV Plus enzyme. The reaction mixture 
was diluted with sterilised ddH2O to a volume of 100 µl and split into five 20 µl 
aliquots. Four of the reaction mixture aliquots were placed into incubation at 
30 C for 1, 2, 4 & 6 hours to compare the effectiveness of digestion. 
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2.4 Protein quality validation 
2.4.1 SDS-PAGE 
SDS-PAGE was carried out in order to isolate and identify protein species 
within samples of cell lysate and purification fractions. Samples were prepared 
through mixing with appropriate volumes of NuPAGE® LDS sample buffer 
(×4) and sample reducing buffer (×10) (Life Technologies). Samples were 
then incubated at 70°C for 10 min on a heating block. Once incubated, 
samples were loaded onto a pre-cast Novex® 4-10% Bis-TRIS gel, 
suspended in 400 ml NuPAGE® MOPS SDS running buffer. Gels were then 
run at 165 V for 35-40 min and were recovered from gel moulds and stained 
through 15 min incubation in QuickBlue gel stain on a rocking platform. 
Following staining, gels were incubated overnight in triple-distilled water to 
allow excess stain to diffuse away, improving contrast between stained 
proteins and the clear background. 
2.4.2 Protein concentration 
The concentration of recovered proteins was predominantly determined 
through UV absorbance recorded using a DS-11+ spectrophotometer 
(Denovix). Concentrations were recorded using the ‘A280’ application on the 
device, with 1 µl buffer used as a blank to provide a base of the readings. 1 µl 
of sample was them applied and the protein concentration and absorption at 
280 nm and 260 nm, with the concentration calculated based on the extinction 
coefficient of Kv1.1-TY10 of 74000 M-1cm-1 predicted by the online analysis 
tool ProtParam (Gasteiger et al. 2005). Each recording was taken in triplicate. 
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2.4.3 Western blotting 
SDS-PAGE gels for western blotting were generated using the methods 
detailed in section 2.4.1, however unstained gels were used for each blot. 
Gels were prepared for western blotting by trimming away the wells and exit 
channel of each gel, followed by soaking for ~5 min in Towbin buffer (25 mM 
Tris, 192 mM glycine, 20% [v/v] methanol, pH 8.3). In parallel to this, six 6 cm 
× 8 cm pieces of blotting paper and one 6 cm × 8 cm nitrocellulose membrane 
were also soaked in Towbin buffer for ~10 min. Stacks of three buffer-soaked 
pieces of blotting paper were then built, with the soaked nitrocellulose placed 
on top of the stack. The Towbin buffer-soaked gel was placed on top of the 
membrane and the remaining three pieces of soaked blotting paper were 
placed over the membrane to form completed stacks. A roller was used to 
gently remove any air bubbles trapped between the different sheets of stacks. 
Blotting stacks were placed into a Bio-Rad Trans-Blot Turbo Transfer System 
transfer cassette. The cassette was loaded into the Transfer System hub unit 
and the blot transfer conducted with a 1 amp, 25-volt maximum program run 
for 30 min. Once the transfer program was concluded, the cassette was 
removed and the nitrocellulose membrane was retrieved from the stack. Gels 
were also recovered at this point and stained as described in section 2.4.1 to 
check the effectiveness of each transfer. 
Nitrocellulose membranes were then placed into a 150 ml sterile metal cap 
tube and washed for 1 hr on a rolling platform with a 30 ml tris buffered saline-
tween 20 (TBST) solution + 10% (v/v) blocking agent from a BM 
Chemiluminescence Western Blotting Kit (Roche; Sigma-Aldrich). The 
55 
 
blocking solution was then discarded by decanting and a 10 ml TBST solution 
featuring diluted primary antibody and 1% (v/v) blocking agent was applied to 
the membrane. The membrane was allowed to incubate on a rolling platform 
overnight at 4°C. 
Following incubation, the primary antibody solution was discarded by 
decanting and the membrane washed thrice with 20 ml TBST. Washing was 
carried out for 15 min on a rolling platform at room temperature. Secondary 
anti-mouse/rabbit antibody (Roche; Sigma-Aldrich) diluted 10000-fold into 
TBST + 1% (v/v) blocking agent was then applied to the membrane and 
incubated for 1-2 hrs on a rolling platform at room temperature. Remaining 
secondary antibody was then removed via decanting and the membrane 
washed thrice once again with 20 ml TBST following the same approach as 
the previous wash. 
The binding of the primary and secondary antibodies was then visualised 
through chemiluminescence using the application of 5 ml of solution A and 50 
μl of solution B supplied with the BM chemiluminescence western blotting kit. 
Fluorescence on the nitrocellulose membrane was recorded in a G:Box 
imaging cabinet, with photos recorded using the Intelli-Chemi function 
included in GeneSnap software (SynGene). 
2.4.4 SEC-MALS  
Size-exclusion chromatography/multi-angle static light scattering (SEC-
MALS) was conducted under the supervision of Dr Maren Thompsen. Multi-
angle static light scattering (MALS) was conducted using a DAWN 8+ light 
scattering detector (Wyatt Technology) and Optilab T-rEV refractive index 
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detector (Wyatt Technology). These instruments record light scattering 
(LS)/quasi-elastic light scattering (QELS) and refractive index (RI), 
respectively. Fresh buffer without protein was used as a reference for the RI 
in the absence of protein, allowing the difference of refractive index (dRI) to 
be calculated.  
SEC-MALS was performed in conjuncture with fluorescence size exclusion 
chromatography (F-SEC) on a Superdex 200 5/150 column (GE Healthcare) 
using a SIL-20AC injector and LC-20AD pump. Buffers for SEC were 
degassed before application to the column. 
UV/visible light absorption of SEC elution fractions was recorded using an 
SPD-M20A photodiode array detector (Shimadzu), with EYFP fluorescence 
recorded using an RF-20A fluorescence detector (Shimadzu). Elution 
fractions from SEC were collected using an FRC-10A fraction collector 
(Shimadzu). Data output from the process was visualised and manipulated 
using the ASTRA programme suite (Wyatt Technology). All assays were 
conducted at room temperature. 
2.4.5 Circular dichroism spectroscopy 
2.4.5.1 Measurement of protein secondary structure 
Circular dichroism (CD) spectroscopy is a method of non-destructively probing 
the folded state of molecules by measuring the absorbance of different 
wavelengths of light in the visible and infrared electromagnetic waves. Alpha-
helices and beta-sheets have distinctive absorbance profiles; thus, CD 
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spectroscopy can be employed to determine the folding and secondary 
structure constitution of proteins. 
CD measurements were performed on a Chirascan Plus spectropolarimeter 
(Applied Photophysics). Additionally, a rotating 6 cell changer carousel and 
Peltier temperature control unit were included in the setup, allowing multiple 
samples to be investigated in parallel and the temperature of cells controlled, 
respectively. 1 mm glass cuvettes were loaded with 200 µl of sample at 
concentrations of 0.2 mg/ml. The spectropolarimeter was programmed to 
measure absorbance at wavelengths 180-260 nm at intervals of 1 nm. 
Measurement of absorbance from 200 µl of buffer without protein was 
conducted in parallel to allow subtraction of background signal. 
Data were analysed using the online tool Dichroweb (Lobley et al. 2002, 
Whitmore, Lee and Wallace 2004, 2008). 
2.4.5.2 Measurement of protein denaturation through temperature ramp  
Temperature ramps can be employed in parallel with real time CD 
spectrographic analysis to give insights into the stability of proteins by 
observing the temperature at which absorbance at various wavelengths 
change. 
Temperature ramping of Kv1.1 samples was conducted using the same 
protocol as measurement at static temperatures. However, the temperature 
of the sample cuvette was increased by 1 C over the course of two minutes 
between each reading, beginning at 25 C and concluding at 99 C. The CD 
ChiraScan software was programmed to record only once the temperature of 
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the vessel had been stable at the target temperature for at least 30 seconds. 
Measurements of absorbance between 180 and 260 nm at each temperature 
mark. 
2.4.6 Mass spectrometry 
Mass spectrometry was conducted by Dr. James Ault in the University of 
Leeds Faculty of Biological Sciences Mass Spectrometry Facility. The gel was 
run using pre-cast NuPAGE Novex 4-12% Bis-Tris at 165 V for 30 min; 10 µl 
of each sample was loaded into each lane (including laurel DS and reducing 
buffer). The gel was stained with Instant Blue stain for 15 min in a sterile plastic 
container to reduce keratin contamination. SDS-PAGE gels (conducted using 
method discussed in section 2.4.1) with the desired protein were provided to 
Dr Ault and gel lanes were excised by Dr. Rachel George of the Mass 
Spectrometry Facility. Gels supplied to the facility for analysis were stained 
using InstantBlue comassie stain (Expedeon), in accordance with the request 
of facility operators to avoid interference in signals. 
Protein identification (Protein ID) via mass spectrometry was carried out 
through the in-house Synapt HDMS system (Waters). Output data from 
protein ID was analysed using an online-enabled UltiMate 3000 HPLC system 
(Dionex) in combination with ProteinLynx Global Server software. 
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2.5 Structural analysis 
2.5.1 Negative stain electron microscopy 
2.5.1.1 Grid preparation 
Negative stain grids were produced using 10 nm carbon-coated copper grids 
(Agar Scientific). A surface charge was applied to grids through glow 
discharge using a PELCO easiGlow™ Glow Discharge Cleaning System; 
grids were placed into the glow discharge chamber carbon-side-up on a 
parafilm-coated glass slide, with the discharge typically lasting 30 seconds. 
Glow discharge was used to ensure that the grid surface was made 
hydrophilic, attracting water-based solutions to the grid and that protein 
molecules are attracted to the surface of the grid. 
Protein solutions were applied to grids in 3 µl droplets onto the carbon coated 
side of the grid. Protein solutions were left on the surface of the grid for 1 min, 
then removed by blotting. This was followed by the application of 3 µl of 1% 
uranyl acetate onto the grid, which was allowed to settle for 1 min, before 
being removed by blotting; this was followed by a further 1 min application of 
1% uranyl acetate, which was removed by blotting. The grid was then air dried 
under a lamp. Minor variations in stain depth was achieved by varying staining 
times. Uranyl acetate was produced and supplied by Astbury Biostructure 
Laboratory (ABSL) support staff.  
2.5.1.2 Data collection 
Data was typically collected on the in-house T12 electron microscope (FEI; 
now ThermoFisher Scientific), operating at 120 kV using a LaB6 filament.  
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Images were recorded using a Gatan CCD camera; originally a 2k × 2k 
camera, which was later replaced by a Gatan 4k × 4K CCD camera.  Images 
were recorded at a typical magnification of 30,000×. Lower screen 
magnifications were used in initial screening to search for aggregation and to 
search for areas with staining depths which provided optimal contrast for 
particle identification. 
2.5.1.3 Data processing 
Data from negative stain electron microscopy were analysed using the 
EMAN2 micrograph processing software (Tang, G. et al. 2007). Manual 
picking of particles was handled using the e2spt_boxer.py tool, followed by 
the generation of 2D classes by the e2classaverage3d.py tool. EMAN2 aligns 
data using correlation co-efficiencies by which each particle is compared to a 
reference.  These references can be determined either by the user by 
manually picking “representative” data or automatically by EMAN2. 
2.5.2 Cryo-electron microscopy 
2.5.2.1 Grid preparation 
Cryo-EM grids were prepared using a Vitrobot automated vitrification module 
(FEI). The environment of the sample application chamber was programmed 
to set conditions at 100% humidity at a temperature of 4°C. Grids were 
charged prior to sample application through glow discharge using an easiGlow 
discharge cleaning system (PELCO), with discharge times typically lasting 45 
sec. Charged grids were then held in tweezers and placed in a specialised 
holding position in the sample chamber of the Vitrobot. Grids were blotted with 
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Whatman qualitative filter paper. The programmed blot force was 6 and 
starting blot time of 6 seconds, followed by flash cooling in liquid ethane. 
Prepared grids were then taken forward to screening on an F20 electron 
microscope (FEI) at a tension setting of 120 kV with micrographs recoded 
using a CMOS detector. 
Proteins samples for cryo-EM were applied to a series of grid types during the 
process of optimisation and screening (see Table 2.7). Multiple diverse types 
of grids were used as variations in surface compositions, hole sizes and hole 
spacing can greatly influence the behaviour of buffers and proteins during 
application, freezing and visualisation. The use of a wide variety of grid types 
thereby allowed single samples to be tested and screened in a multitude of 
environments. 
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Grid type Hole dimensions Hole spacing  Image 
Carbon 
10 nm × 10 nm 
square 
2 nm 
 
Lacey carbon Variable Variable 
 
Holey carbon Variable Variable 
 
Quantifoil R 1.2/1.3 
1.2 µm diameter 
circle 
1.3 µm 
 
Quantifoil R 2/1 
2.0 µm diameter 
circle 
1.0 µm 
 
Quantifoil R 2/2 
2.0 µm diameter 
circle 
2.0 µm 
 
 
Table 2.7 – Table of grid types used in preparation of Kv1.1 samples 
for cryo-EM (Quantifoil Micro Tools GmbH. 2015a; Quantifoil Micro 
Tools GmbH. 2015b; Agar Scientific Ltd. 2018; Electron Microscopy 
Sciences 2018). 
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Frozen grids were then transferred into plastic holding pucks under liquid 
nitrogen and then stored before screening in storage dewars containing liquid 
nitrogen before screening. 
Similar to uranyl acetate staining in negative stain microscopy, it is generally 
preferable to keep ice as thin as necessary to stably sustain protein particles 
suspended in the grid holes. Producing ice with the optimal thickness often 
requires modifying the parameters of grid freezing machinery. To ensure good 
ice quality with low contrast, it is best to use buffers with low concentrations 
of buffering agents and additives. 
2.5.2.2 Data collection 
Prior to the construction and activation of the in-house Astbury Biostructure 
Laboratory (ABSL), cryo-EM grids were shipped to the Electron Microscope 
facility at the MRC Laboratory of Molecular Biology, University of Cambridge, 
where samples were screened and sets of micrographs taken using a Krios 
electron microscopes (FEI) with a K2 direct electron detector (Gatan). Once 
the in-house ABSL facility was brought online in June 2017, grid screening 
and data acquisition were moved to the on-site Krios 1 electron microscope. 
2.5.2.3 Data processing  
Processing of cryo-EM data was handled using the Regularised Likelihood 
OptimisatioN program (Relion) (Scheres, S. H. W. 2012). Data processing 
was carried out on dedicated Astbury Biostructure Laboratory workstation 
servers. .ser files were converted to. mrc format using a custom program 
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developed in-house by Dr Matt Iadanza, allowing the data to be imported into 
Relion for processing. 
Data processing commenced with motion correction of the images using CTF 
(contrast transfer function) estimation. Particles in micrographs were then 
selected through manual picking of a selection of images. 
2.6 Kv1.1 coincubation with alpha-dendrotoxin 
0.4 mg/ml Kv1.1-TY10 purified via IMAC on cobalt resin was coincubated with 
10 mM alpha dendrotoxin (α-DTX) in 150 mM NaCl, 50 mM Tris, 10 mM KCl 
pH 7.6 buffer for 30 min on ice. The mixture was then placed into a 10-250 µl 
mini GeBAflex-tube for dialysis (Gene Bio-Application) and placed into a 
beaker with 200 ml fresh buffer and allowed to dialyse for 10 min at 4 C. 
Following dialysis, the tube was transferred to second beaker for a further 10 
minutes with 200 ml of fresh buffer to ensure complete removal of remaining 
toxin.
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3 Expression of Kv constructs in HEK cell culture 
3.1 Background 
Voltage-gated potassium channels are predominantly expressed in 
electromechanically sensitive cell types, such as neurons and smooth muscle 
cells (Jackson 2005, Vacher et al. 2008). While extraction of protein directly 
from samples of neuronal cells would likely provide protein under conditions 
most closely resembling its natural state, securing such materials for the study 
of the human variant of Kv family proteins would require human tissues, which 
would raise serious ethical concerns. The use of HEK 293 cell culture was 
chosen in order to avoid these ethical issues. 
The ability to transfect HEK cells in culture allowed protein to be generated 
using human cells through well-developed expression protocols. This also 
allowed genes to be modified with tags and point mutations, which would not 
be possible if sourced from natural tissues. While greater flexibility of gene 
modification is available in bacterial expression systems, they are inadequate 
for expressing human membrane proteins, due to the significant differences 
in bacterial membrane compositions and expression machinery (Wagner, S. 
et al. 2006). 
HEK cells are compatible with both adherent and suspension culture with both 
approaches to cell cultivation having advantages and drawbacks. Adherent 
cell culture is generally simpler to establish, as the flasks do not require 
constant agitation, making the possibility of mechanical damage to cells much 
more remote. However, adherent culture flasks are less efficient, as cells are 
not able to take full advantage of the total volume of the flask. 
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Suspension culture of cells allows for much more efficient use of space, as 
cells are spread throughout the full volume of the flask; this makes increasing 
the scale of cultures less problematic, however cells grown in suspension are 
sensitive to more environmental factors. If conditions are not correct, cells can 
be prone to clumping and falling out of suspension, leading cells at the centre 
of clusters to starve. Excessively high rotation speeds for agitation can also 
destroy cells due to the increased risk of shearing. 
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3.2 Cloning and constructs 
3.2.1 Kv1.1 constructs 
Multiple Kv1.1 constructs with C-terminal tags were designed to give flexibility 
in purifying the protein. The generation of the constructs discussed in sections 
2.1.1.3 and 2.1.1.4 was carried out using the PCR method detailed in section 
2.1.2. The annealing temperatures for PCR was based on the predicted 
melting temperatures of the forward and reverse primers used. The native 
KCNA1 and KCNA1-EYFP constructs in pcDNA6 were used as the basis for 
the initial set of modified constructs. 
3.2.1.1 Kv1.1-EYFP-His6 
The Kv1.1-EYFP-His6 was produced from the KCNA1-EYFP construct using 
the primers detailed in section 2.1.1.3 to eliminate the stop codon at the 
terminus of the EYFP gene, allowing the gene to read through into the 
hexahistidine motif encoded at the pcDNA6 polyclonal site. 
Following PCR, two bands were observed in an agarose gel of the post-
reaction mixture. The longer of the two bands was the best match for the 
expected length of the product (Figure 3.1). The longer band was cut out of 
the gel under UV light and the DNA recovered using the Qiagen QIAEX II gel 
extraction kit. The linear PCR product was then treated with DpnI in order to 
digest any remaining methylated parent plasmid DNA and the purified PCR 
product was ligated using T4 polynucleotide kinase and T4 ligase. A second 
reaction with the ligase omitted was set up to produce a negative control. Both 
the ligation and negative control were carried forward into a heat shock 
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transformation for XL1-Blue supercompetent cells and plated on 100 µg/ml 
ampicillin inoculated LB agar plate; these were cultured overnight at 37°C. 
 
 
Figure 3.1 – Agarose gel of PCR product from KCNA1-EYFP 
mutagenesis. A band which approximately corresponds to the 
expected 7.2 kbp length of the PCR product can be observed in the 
PCR product lane. The band was purified through excision from the 
agarose gel, followed by gel extraction. Subsequent sequencing of the 
extracted band confirmed its identity to be the desired modified 
plasmid. 
~100 transformants were observed the following day on the ligated reaction 
plate; a smaller number of colonies were observed on the negative control 
plate, though as only 9 were observed, it was determined that the majority of 
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the colonies on the ligation plate constituted genuine transformants. The 
decision was made to culture 6 colonies (A-F) from the ligated reaction plate. 
Colonies B, C, E and F grew sufficiently for DNA to be recovered via Qiagen 
miniprep. Colony PCR was then used to check for the presence of the Kv1.1 
plasmid (Figure 3.2). The results of PCR mutagenesis were confirmed via 
Sanger sequencing. 
 
Figure 3.2 – Agarose gel of miniprep products. DNA from colonies B, 
C and E appeared to be the correct length, approximately matching the 
expected 7.2 kbp size of the plasmid. The DNA from culture F, 
appeared to be shorter in length, possibly as a result of incorrect 
priming of the template. 
 
3.2.1.2 Kv1.1-TEV-EYFP-His6 
Following the production of a pcDNA6 plasmid encoding Kv1.1-EYFP-His6, a 
further construct was devised which incorporated a TEV cleavage site into the 
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region between Kv1.1 and the C-terminal tags. Such a plasmid would encode 
a Kv1.1-TEV-EYFP-His6 construct, which could be digested with TEV protease 
in order to remove the tags. Such a construct could be further purified via 
reverse-purification, as removal of tags following primary purification with 
antibody resin or IMAC-based methods could be repeated post-digestion. 
Removal of tags would likely be of benefit to structural analysis, also, with the 
elimination of domains at the end of flexible linkers resulting in more ordered 
samples (Eschenfeldt, W. H. et al. 2010). 
Plans to modify the Kv1.1-EYFP-His6 construct to include a TEV cut site 
between the Kv1.1 and EYFP genes and generate a Kv1.1-TEV-EYFP-His6 
construct were not initially successful; ligated plasmid recovered following 
PCR all displayed deletions at the site of ligation. One PCR product had a 3-
nucleotide deletion which resulted in the loss of the internal phenylalanine of 
the TEV site, while preserving the downstream genes in-frame. As this 
construct could in theory be expressed and retain functional EYFP and 
polyhistidine, it was kept for possible use in the event that an extended linker 
would be necessary. This plasmid was dubbed ‘KCNA1-PartTEV-EYFP-His6’ 
and a new series of primers were designed to insert the missing phenylalanine 
and produce a functional TEV cleavage site. 
The construct was completed by introducing the missing phenylalanine 
residue via PCR mutagenesis using the following primers, with melting 
temperatures of 58.6 ºC: 
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>KCNA1-FullTEV-EYFP-His_Forward 
cagagcgtgagcaagggcg 
>KCNA1-FullTEV-EYFP-His_Reverse 
gaagtacaggttctcgaattcaacatcggt 
The standard PCR method discussed in section 2.1.2 was applied to the 
KCNA1-PartTEV-EYFP-His6 plasmid using the new primers above. Sanger 
sequencing of the product band for this indicated that the missing 
phenylalanine was inserted, completing the desired plasmid (Figure 3.5). 
3.2.1.3 Kv1.1-TEV-EYFP-His10 
A Kv1.1-TY10 construct was produced from the above hexa-histidine-tagged 
counterpart through the use of primers to add a series of 4 additional histidine-
encoding codons (CAT/CAC) to the C-terminal of the hexahistidine motif, 
upstream of the stop codon.  
3.2.2 Kvβ2 constructs 
3.2.2.1 Native KCNAB2 
KCNAB2 cDNA was cloned from human foetal brain cDNA through PCR 
amplification using the primers detailed in 2.1.1.4. The forward primer included 
a 5′ EcoRI restriction site, while the reverse primer featured a 3′ XbaI 
restriction site to allow restriction and ligation of the cDNA into the polyclonal 
site of pcDNA3.1. A Kozak consensus sequence was included directly 
upstream of the KCNAB2 start codon in order to boost transcription. 
Restriction ligation of KCNAB2 into the polyclonal site of pcDNA3.1 was 
confirmed via sequencing. 
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The PCR product band was excised from the gel and recovered using a 
QIAEX II gel extraction kit (QIAGEN) and blunt ligated into the pJET1.2 
cloning vector, as per the method detailed in section 2.1.1.4. Transformation 
into XL-1 blue bacteria and overnight culture on 100 µg/ml ampicillin plates 
resulted in ~200 colonies. 6 colonies were selected and grown in suspension 
in Liquid LB, with 100 µg/ml ampicillin. One colony failed to grow in 
suspension, while the remaining five grew sufficiently for plasmid DNA 
recovery via miniprep (Figure 3.3). 
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Figure 3.3 – Agarose gel of PCR product from primers designed to 
extract the human kcnab2 gene from foetal human brain cDNA. The 
length of the expected product, based on the length of the target gene, 
is 1.1 kbp, which correlates with the weight of the product band 
observed in the PCR lane.  
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3.2.2.2 KCNAB2-cMyc-His6 
The pcDNA3.1 plasmid encoding native KCNAB2 discussed in the previous 
section was used as the basis for the production of a tagged variant of the 
gene. The KCNAB2-cMyc-His6 primers discussed in section 2.1.1.4 were 
used in conjuncture with PCR, using the predicted melting temperatures as 
the basis for the annealing temperature of 61.4°C used in PCR programme 
(see section 2.1.2 for details), in order to clone a version of the plasmid with 
the native stop codon deleted, allowing the gene to read through into the cMyc 
and His6 tags encoded at the 5’ end of the pcDNA3.1 plasmid polyclonal site. 
The PCR mixture programme discussed above was subjected to DpnI digest 
following the reaction. Agarose gel electrophoresis of the digested reaction 
mix revealed a band, which was subjected to blunt end ligation with TA ligase 
(New England BioScience). 
3.3 Transient transfection of HEK cells 
Initial expression trials of C-terminal tagged Kv1.1 constructs were aimed 
toward comparing the effectiveness of the FuGENE HD and PEI-based 
methods for mammal cell transfection (see section 2.2.3 for details). The 
Kv1.1-TEV-EYFP-His6 construct was used in these trials, as the EYFP tag 
would allow quick visual identification of transfected cells through 
fluorescence microscopy. 
To obtain sufficient DNA for each transfection, Kv1.1-TEV-EYFP-His6 plasmid 
was recovered via maxiprep kits and repeated in triplicate. Amounts of 
recovered DNA were quantified using ultraviolet absorbance spectroscopy; on 
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each occasion, a total mass of ~1 mg of DNA was recovered, which was a 
sufficient quantity for PEI-mediated transient transfection of HEK cells 
adhered to the base of a T75 flasks. 
Transfection using both FuGENE HD and PEI were tested in small-scale using 
HEK 293 TSA cells on 35 mm dishes, with a culture volume of 2 ml (Figure 
3.4). Inspection of the plates 48 hours post-transfection on a fluorescence 
microscope at 10 magnification (see section 2.2.5 for details) revealed that 
~30% of cells displayed signs of fluorescent protein expression without any 
signs of changes in morphology or retardation of growth. 
While the appearance of fluorescence within the transfected cell population 
suggested the expression of the EYFP-tagged fusion proteins, it was not 
immediately clear at that stage, however, if the protein produced was correctly 
folded or localised to the plasma membrane, only that protein had been 
expressed. 
Using PEI-based transfection methods necessitated continual establishment 
and culturing of XL1-Blue E. coli in order to clone plasmids for protein 
expression, followed by maxiprep of 5-20 g quantities of cell pellet, which 
proved to be more time consuming than the equivalent FuGENE-based 
method. As FuGENE is capable of transfection efficiencies comparable to PEI 
at µg quantities, requiring lower quantities of cell pellet to produce, as well as 
quicker miniprep methods from cell rupture and DNA collection, FuGENE-
based methods were selected for all mammal cell transfection subsequent to 
comparison to reduce the required time investment to generate the quantities 
of DNA necessary for PEI-based transfection.
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Figure 3.4 – A fluorescence microscope views of HEK293 TSA cells transiently transfected with a pcDNA6 plasmid encoding 
Kv1.1-TEV-EYFP-His6. In the instance of a) the cells have been transfected using the FuGENE HD reagent and in the instance 
of b) the cells have been transfected using PEI. The appearance of regions of green fluorescence across the cell populations in 
indicates that the cells had been transfected by the plasmid and had begun to express the EYFP-tagged protein in both cases.
100 µm 100 µm 
a) b) 
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3.4 Stable transfection 
3.4.1 Hexahisitide tagged construct, Kv1.1-TEV-EYFP-His6 
Stably transfected HEK 293S GnTI- cells expressing the Kv1.1-TEV-EYFP-
His6 construct were generated using the methods outlined in section 2.2.4. 
Cells were transfected using the FuGENE HD reagent method and seeded at 
10% confluence into a T25 tissue culture flask and grown at 37°C in 5 ml of 
DMEM:F-12 medium. After 6 days, the media was removed via aspiration and 
replaced with 5 ml of fresh DMEM:F-12, with 100 ng/μl blasticidin added to 
apply selective pressure. Cells were cultured following the methods detailed 
in section 2.2.4. 
Following a further 7 days incubation, cells were treated with trypsin and re-
seeded at ~0.1% confluence onto a 10 cm2 tissue culture dish and grown for 
10 days at 37°C. Twelve individual colonies from the tissue culture dish were 
selected following incubation and transferred into 2 × 6-well plates. Each well 
was filled with 2 ml DMEM/F-12 media containing 100 ng/μl blasticidin. Cells 
were collected from the source plate through gentle scraping and aspiration 
using a 20 µl pipet tip; 2 µl drawn up into the pipette for each colony and then 
transferred into a plate well. 
Following 14 days incubation, two fluorescent colonies were observed 
growing in well C2; both colonies displayed homogenous fluorescence 
throughout, potentially indicating them to be monoclonal. 
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3.4.2 Decahistodine tagged construct, Kv1.1-TEV-EYFP-His10 
Stably transfected HEK 293S GnTI- cells expressing Kv1.1-TY10 were 
generated via the same method as discussed above in section 3.4.1, with cells 
transfected using the FuGENE HD reagent method and seeded at 10% 
confluence into a T25 tissue culture flask and grown at 37°C in 5 ml of 
DMEM:F-12 medium. After 6 days, the media was removed via aspiration and 
replaced with 5 ml of fresh DMEM:F-12, with 100 ng/μl blasticidin added to 
apply selective pressure. 
Following a further 5 days incubation, cells were trypsinised and re-seeded 
onto a 10 cm2 tissue culture dish at a confluence of ~0.1% and incubated for 
10 days at 37°C with 5% atmospheric concentrations of CO2. The dish was 
then placed under a light microscope and six colonies from the tissue culture 
dish were selected for transfer into separate wells into a tissue culture grade 
6-well plate through gentle scraping and aspiration using a 20 µl pipet tip. 
Each well was filled with 2 ml DMEM/F-12 media containing 100 ng/μl 
blasticidin. The plate was placed into a 37°C incubator with a 5% ambient 
atmospheric CO2 concentration for culturing. 
Following 10 days incubation, four fluorescent colonies were observed 
growing in different wells, which were labelled colonies I-IV.  Colonies I and 
IV displayed homogenous fluorescence, with fluorescence in colonies II and 
III being too dim to accurately assess their quality. Cells from colony IV were 
taken forward for expression of Kv1.1-TY10, with colony I cells stored as a 
back-up cell line.  
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3.4.3 Kv1.1-TEV-EYFP-His10/KCNAB2 double transfection 
Following the development of a stably transfected cell lines for expression of 
Kv1.1, a doubly transfected cell line expressing native Kvβ2 was conceived in 
order to express the octameric complex, which would allow the effects of the 
beta subunits on inhibitor binding to be included in structural studies, as well 
as its intrinsic regulatory effects to be assessed in characterisation trials. The 
Kv1.1-TY10 colony IV cell line was used as the basis for the development of 
this new cell lineage. 
Colony IV cells were transfected via FuGENE HD with the pcDNA3.1 plasmid 
encoding native KCNAB2 through the method discussed in section 2.2.4. 
Cells were seeded into a T25 cell culture flask at a density of 10% with 5 ml 
DMEM:F12 medium supplemented with 10% FBS and 1% penicillin-
streptomycin. 
Selective pressure applied with both 500 ng/µl G-418 (an equivalent of 
neomycin), as well as 100 ng/µl blasticidin. These antibiotics were selected in 
order to select for the pcDNA3.1 encoding the native KCNAB2 gene, as well 
as pcDNA6 plasmid encoding Kv1.1-TY10, respectively. A starting 
concentration of 500 ng/µl was used based on antibiotic regimes used in 
similar stably transfected cell lineages expressing BK channel/β2 co-
expression cell lines conducted by other members of the Lippiat Group. 
The transfected cells failed to thrive and dislodged from the plate surface after 
6 days of incubation, indicating that they had died. Transfections were 
repeated a further two occasions without modification of the protocol in order 
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to ensure that the cell death was not a result of errors in cell culture, however 
the cells died after 5 and 6 days in these instances, respectively. 
A killing curve of single stable transfection Colony IV line cells was conducted 
with varying concentrations of G-418 to check if concentrations of the 
antibiotic were excessively high. The killing curve would allow the minimum 
concentration of antibiotic required for the killing of cells lacking resistance to 
be discerned. The killing curve was conducted in a 6-well plate seeded with 
10% confluence of cells. The wells were filled to 2 ml with DMEM:F20 
supplemented with 10% FBS, 1% penicillin/streptomycin and inoculated with 
100 ng/µl each of blasticidin. Each separate well was inoculated with a 
different concentration of G-418, ranging 0, 100, 200, 300, 400 or 500 ng/µl. 
The growth of cells was monitored via light microscopy. Over the course of 
the following 7 days, cells growing in 0, 100 and 200 ng/µl concentrations of 
G-418 survived, while cells grown at high concentrations dislodged from the 
surface of the plates. 
3.5 Comparison of suspension culture media 
3.5.1 Influence of different media types on cell growth 
Suspension cultures of stably transfected Colony VI line HEK 293S GnTI- cells 
expressing Kv1.1-TY10 (see section 3.4.2 for details) were used in assessing 
the rates of HEK cell growth in suspension culture. Cell numbers in 180 ml 
starter cultures were monitored on a Countess cell counting machine until cell 
densities reached 2×106 cells per ml. Following this, 30 ml of cells were then 
taken from suspension and used to inoculate two further 150 ml cultures at 1 
in 6 in 500 ml tissue culture grade conical flasks. The remaining 150 ml of both 
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cultures were induced through the addition of 5 mM sodium butyrate. Cells 
were harvested through centrifugation 48 hrs after introducing sodium 
butyrate, then washed twice with 25 mM DPBS. The final volume of cell paste 
was slightly under 5 ml. 
To try and maximise the number of cells grown and resultant protein extracted 
different approaches were taken to check the effectiveness of other media in 
place of PEM as a means of increasing efficiency and reducing costs. 4 new 
cultures were set up from 20 ml of PEM culture grown to 2×106 cells per ml, 
then placed into 160 ml of new culture medium. FreeStyle, EX-CELL and 
DMEM/F-12 medium was compared against a PEM culture in parallel using 
Countess recordings of cell count and viability (Figures 3.5). 
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Figure 3.5 – Cell growth and viability over time in suspension culture 
across a series of medium types. Cell viability was calculated from the 
recorded number of living cells divided by the total cell count (living cell 
count / total number of living cells + total number of dead cells).  
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The results of the growth trials indicate that growth rates are highest in PEM, 
though FreeStyle and EX-CELL both allow for sustained growth at slightly 
slower rates. All three media have comparable viabilities and similar market 
prices; a comparison of HEK 293S GnTI- cell growth and viability in each 
medium type was conducted in order to identify the most cost-effective option. 
DMEM/F-12 medium appears to be unsuitable for sustaining HEK 293S GnTI- 
cells in suspension, however. This may be due to excessive calcium found in 
the medium. Further experiments with calcium-free DMEM will be required to 
confirm this hypothesis. 
To assess the flexibility of the protocol used to grow human cells in 
suspension culture, the effectiveness of EX-CELL medium in establishment 
of suspension populations was compared directly with FreeStyle medium, 
which had been used in all previous trials (Figure 3.6). 
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Figure 3.6 - Work-flow diagram describing the development of cell cultures in FreeStyle 293 and EX-CELL medium for the 
comparison of cell growth in both medium types.
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Establishment cultures were allowed to acclimatise to suspension culture for 
4 days in a shaking incubator at 120 rpm, with an ambient temperature of 37°C 
and 5% atmospheric concentrations of CO2. At the conclusion of the 96-hour 
establishment period, a total cell count was taken using the Countess 
electronic cell counting system (Table 3.1). 
 
 FreeStyle medium EX-CELL medium 
Live cell count (cells/ml) 1.1×106 8.1×105 
Dead cell count (cells/ml) 2.7×104 3.2×104 
Live cell percentage 98% 96% 
 
Table 3.1 – Table of living and dead cells counted in 180 ml starter 
cultures 96 hrs after establishment in FreeStyle and EX-CELL media. 
 
Both of the media used sustained stably transfected HEK 293S GnTI- cells for 
96 hrs without requiring a change of medium or addition of extra supplements. 
Both starter culture flasks were inoculated with an approximately equal 
number of cells grown in adhered culture in 30 ml DMEM-F12 in T175 flasks. 
Cells grown in both media displayed a similar ratio of living and dead cells, 
however FreeStyle medium appears to maintain a higher proportion of living 
cells. Cells grown in FreeStyle medium also displayed a 74% increase in the 
number of live cells recorded per ml. 
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Both FreeStyle and EX-CELL cultures were then diluted 1:1 into 500 ml plastic 
Erlenmeyer flasks containing 90 ml EX-CELL medium supplemented with the 
same additives as the establishment cultures. The flasks were returned to the 
incubator and grown under the same conditions as the establishment cultures. 
Cell counts were then taken daily until the live cell population of one of the 
suspension cultures approached 2×106 (Table 3.2). Following 3 days of 
further cell culture, the FreeStyle-derived cells came close enough to this 
boundary that the decision was taken to stimulate protein expression with the 
addition of 5 mM sodium butyrate. 
 
 FreeStyle medium EX-CELL medium 
Live cell count (cells/ml) 1.8×106 8.6×105 
Dead cell count (cells/ml) 5.7×104 7.8×104 
Live cell percentage 97% 92% 
 
Table 3.2 – Table of living and dead cells counted in 180 ml FreeStyle 
and EX-CELL cultures 72 hrs after transfer from starter cultures. 
 
Both types of media continued to maintain cells in solution with high vitality, 
with >90% of cells counted in both types of media being live. By this stage, 
FreeStyle medium displayed ~110% increase in live cell numbers compared 
to EX-CELL medium. 
87 
 
To sustain cell populations post-expression, 20 ml of the FreeStyle-derived 
cells and 40ml of the EX-CELL derived cells were transplanted into fresh 
180ml EX-CELL cultures to create new cultures with a starting density of 
2×105 cells/ml; these were placed into incubation under the same conditions 
as previously discussed in section 2.2.2. Following 48 hrs additional 
incubation with 5 mM sodium butyrate, a final cell count was taken to observe 
the condition of the stimulated cells (Table 3.3). 
 
 FreeStyle medium EX-CELL medium 
Live cell count (cells/ml) 2.3×106 8.9×105 
Dead cell count  1.1×105 1.1×105 
Live cell percentage 96% 89% 
 
Table 3.3 – Table of living and dead cells counted in 180 ml FreeStyle 
and EX-CELL cultures 120 hrs after transfer from starter cultures and 
48 hrs after the addition of 5 mM sodium butyrate. 
 
Both cultures grew following the addition of sodium butyrate, however 
FreeStyle medium displayed the greater growth, with a 27.8% increase in live 
cell population relative to levels lacking sodium butyrate, while the number of 
cells in EX-CELL medium grew by only 3.5% (see Table 3.2). The overall live 
cell percentage in both media decreased, however EX-CELL medium 
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displayed the greater loss in overall population, with a loss of 3%, as opposed 
to 1% lost by FreeStyle medium. 
3.5.2 Influence of pluronic acid and primatone on cell growth in 
suspension 
The results discussed section 3.5.1 were still sub-optimal, as PEM, FreeStyle 
and EX-CELL are all substantially more expensive than DMEM, making them 
less economically viable than DMEM culture. In an effort to improve the vitality 
of cells in suspension DMEM, an additional culture was set up to investigate 
the effects of adding 0.2% (w/v) of the surfactant pluronic acid, which is 
suspected to improve mammal cell resilience to shearing, to calcium DMEM 
produced from commercial hydrated powder (Büssow 2015). Additionally, 
2.5% (w/v) primatone was added as an anti-apoptosis agent (Schlaeger 
1996). Each culture was established in 180 ml of culture, each supplemented 
with 100-fold diluted non-essential amino acid and glutamine. DMEM + 
pluronic acid was compared directly against PEM, FreeStyle and EX-CELL 
media, with each seeded with a starting cell density of ~ 200,000 cells/µl. 
Cell cultures were incubated in 500 ml plastic Erlenmyer flasks at 37 ºC in a 
shaking incubator with a shaking speed of 120 rpm with 8% atmospheric CO2, 
based on a protocol developed from discussion with Dr. Paul Miller at the 
Structural Genetics Consortium, Oxford, UK. Grow rates were recorded 
through cell count readings at 24 hr intervals. 48 hrs prior to collection (at time 
96 hrs) 5 mM sodium butyrate was added to each medium to stimulate 
additional protein production. Cells were collected via the method outlined in 
section 2.2.2 and protein extracted from these cultures were later used in 
mass spectrometry experiments (see section 4.6). 
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In contrast to the growth curves in section 3.5.1, FreeStyle medium 
supplement with Primatone was able to support cell growth at a near-identical 
pace to PEM (Figure 3.7). PEM and FreeStyle media display very similar grow 
curves, with cell number increasing approximately 10-fold in the course of 120 
hours. Growth recorded in EX-CELL is less pronounced, with the cell count 
increasing approximately 5-fold in the same time frame. 
This may be an indication that variation in cell growth between experimental 
setup may obscure the true effects of varying cell medium and supplements. 
Despite being supplemented with both primatone and pluronic F68, the cells 
seeded into DMEM failed to grow – both the cell count and viability of cells in 
this medium dropped for the duration of the growth trial, indicating that while 
primatone is rich in amino acids it is not suitable as an alternative source of 
carbon to FBS. 
Cells in DMEM decrease in number over the course of the experiment, 
reducing by 40% by the conclusion. Following the results discussed above, 
the DMEM-based culture was repeated. However the FBS content of the 
medium was increased to the 10% (v/v) concentration found in adherent 
culture, as recommended in Lin et al., 2015.  
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Figure 3.7 – Graph detailing the number of HEK cells recorded over 
time in suspension culture in PEM, FreeStyle, EX-CELL and DMEM 
when supplemented with pluronic acid and primatone. 
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3.5.3 Effects of media types on protein purification 
HEK cells from suspension were collected in 50 ml falcon tubes through 
centrifugation at 200 × g for 10 minutes. The supernatant was them removed 
and the cells resuspended and washed twice with 50 ml PBS. The pellets of 
FreeStyle and EX-CELL establishment cells were separately pooled and 
weighed, with a final mass of 1.56 g and 900 mg recorded for each medium 
respectively. Both pellets were placed into storage at -80°C. 
Pellets of HEK cells were later thawed for purification to compare the protein 
generated by each medium. The cell pellets were thawed on ice, then 
resuspended in the standard lysis buffer (300 mM NaCl, 50 mM Tris pH 7.6, 
10 mM KCl, Roche EDTA-free protease inhibitor). Protein from both pellets 
was recovered via sonication and 1% (w/v) DDM recovery and then purified 
using gravity column IMAC as detailed in section 2.3.3.2. Due to the difference 
in the cell pellet weights produced by both media, the FreeStyle medium was 
incubated on a larger 180 µl bed volume of HisPur resin, compared to 100 µl 
for EX-CELL derived protein. The volumes of elution buffer used were 
changed to reflect this modification. 
Following the final dialysis step, the 30 mM imidazole wash, 100 mM imidazole 
elution and 250 mM elution faction was concentrated using 50 kDa cut-off 
membrane centrifuge tubes down to volumes of ~150 µl. for SDS-PAGE, 13 
µl samples of each fraction were then mixed with 5 µl ×4 Novex LDS sample 
buffer and 2 µl ×10 Novex sample reducing buffer, then heated to 70°C in a 
metal heating block and allowed to incubate for 5 min. 9 µl of each sample 
were then taken forward to SDS-PAGE (Figure 3.8). 
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Figure 3.8 – SDS-PAGE comparing of the purification fractions of 
Kv1.1-TY10 protein derived from HEK cells suspension culture 
established in FreeStyle vs. EX-CELL medium on HisPur cobalt resin. 
Kv1.1 bands are outlined in green. 
  
L
a
d
d
e
r
In
c
u
b
a
ti
o
n
fl
o
w
-t
h
ro
u
g
h
3
0
m
M
im
id
a
z
o
le
w
a
s
h
1
0
0
m
M
im
id
a
z
o
le
w
a
s
h
2
5
0
m
M
im
id
a
z
o
le
w
a
s
h
L
a
d
d
e
r
In
c
u
b
a
ti
o
n
fl
o
w
-t
h
ro
u
g
h
3
0
m
M
im
id
a
z
o
le
w
a
s
h
1
0
0
m
M
im
id
a
z
o
le
w
a
s
h
2
5
0
m
M
im
id
a
z
o
le
w
a
s
h
Established in
FreeStyle
Established in
EX-CELL
245 kDa
190 kDa
135 kDa
100 kDa
80 kDa
58 kDa
46 kDa
32 kDa
25 kDa
22 kDa
17 kDa
11 kDa
93 
 
The 250 mM imidazole elution fraction derived from EX-CELL medium culture 
was taken forward to cryo-EM (see section 5.3). Column flow-through and 
elution fractions show gradual increases in purity in both cases, however 
protein derived from FreeStyle medium display increased flow-through 
content compared to EX-CELL, though lower yields and higher contamination 
in later elution fractions. In previous purification trials on cobalt resin, the 
highest quantities and purity Kv1.1 was found in the 250 mM imidazole 
fraction. Cells established in FreeStyle appear to generate less Kv1.1 
compared to cells established in EX-CELL, based on the bands observed in 
this gel.  
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4 Purification and characterisation of Kv proteins 
4.1 Background 
The purification of proteins is an essential step in their study and 
characterisation. Separating the target protein from other species is required 
in order to isolate its individual characteristics so that any experimental 
measurements are not affected by contaminants, such as RNA, DNA or other 
proteins. In structural studies, protein samples must be pure in order to allow 
the generation of repeating crystal structures in the case of X-ray 
crystallography, or producing homogeneous, easily-processed datasets in the 
case of electron microscopy (McPherson and Gavira 2014, Thompson, R. F. 
et al. 2016). 
Purification techniques operate by separating proteins based on their physical 
and chemical characteristics. Proteins can be extracted through exploiting 
their specific interactions with binding partners, such as substrates, cofactors 
or antibodies. Purification through polyhistidine tagging is one of the most 
commonly used methods for purifying protein for analysis. Polyhistidine 
tagging involves adding a motif of repeated, consecutive histidine residues to 
the protein, usually between 6 or 12 amino acids in length, either at the N- or 
C-terminus, or more unusually in an unstructured linker region within the 
sequence (Porath 1992). These polyhistidine motifs strongly bind divalent 
metal ions, such as Ni2+ or Co2+ (Bornhorst and Falke 2000). Antibody-based 
purification methods work on a similar principal, with proteins binding to 
antibodies raised to specifically target elements of their amino acid sequence 
and/or their modified surface groups (Urh et al. 2009). 
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Additionally, purification by shape and size are utilised in purification by SEC, 
with columns with resins composed of porous beads. Small molecules are 
more likely to enter the convoluted, included volume of the beads making up 
the resin, while larger molecules will enter the excluded volume and take a 
more straightforward path out of the column, thus molecules tend to elute from 
SEC columns in order of largest to smallest. This process is also effective at 
separating precipitated species from folded proteins and can be combined 
with multi-angle light scattering (MALS) to characterise the mass and radius 
of species eluting from the column (Fekete et al. 2014). 
Proteins removed from their native environment often suffer from issues with 
their structural stability. Optimising factors such as buffer composition, salinity, 
pH, temperature and mechanical pressure can be difficult to determine and 
each is able to perturb the protein structure and promote unfolding. Changes 
in environment and folding can adversely affect the functionality of the protein, 
potentially making characterisation of proteins challenging. 
For membrane proteins, an additional factor to consider is finding a scaffold 
that can house the protein while maintaining both stability and function. 
Typically, this has been achieved through detergents such as DDM but these 
have their own limitations, for example, stripping away many of the closely 
associated lipids. As a result, new technologies have been developed that 
avoid such issues. SMA, for example, can recover membrane proteins while 
retaining natively associated lipids. One limitation of SMA in the industrial 
setting is that although it can be used by academic groups, it is currently under 
some amount of IP protection (Medical Research Council 2014).  Therefore, 
new related systems such as DIBMA have been produced that act in a manner 
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similar to SMA without being restricted by IP. Currently, very little has been 
reported on the use of DIBMA for membrane proteins and part of this work 
was aimed at comparing DDM, DIBMA and SMA to aid future experiments in 
this field. 
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4.2 Comparison of cell lysis methods 
To investigate the best route for protein extraction both the sonication and 
tissue grinding approaches were tested. While sonication as a method of cell 
disruption is often highly effective, rupturing cells into smaller fragments at a 
faster rate, it has been known to generate localised temperature and pressure 
fluctuations which can trigger unfolding of liberated proteins. Homogenisation, 
on the other hand, ruptures cells more gradually, often liberating less useable 
product, while avoiding the generation of unfolded or precipitated proteins 
often seen in sonication. 
The effectiveness of both techniques in the preparation of Kv1.1 was 
compared through SDS-PAGE of the raw soluble and insoluble lysate 
produced from 0.5 g of HEK 293S GnTi- cell pellet via both techniques (Figure 
4.1). Recovery of protein from the insoluble fraction was conducted using 
0.1% DDM and 0.1% SMA to compare the relative effectiveness of each 
detergent. 
Larger quantities of protein in the soluble fraction were observed in the 
samples prepared using sonication compared to homogenisation, though 
approximately equivalent amounts of protein were observed in insoluble 
fractions prepared using either method (Figure 4.1). While the soluble cell lysis 
fraction was not the desired product for the purpose of purification, the higher 
yield of soluble protein in the sonicated sample was interpreted as an indicator 
of more complete lysis of the whole cell pellet compared to homogenisation.  
Sonication was subsequently used over cell homogenisation in the majority of 
later cell purification trials, with the exception of extractions performed using 
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SMA and DIBMA, where homogenisation of cell membranes was 
recommended by Dr. Vincent Postis for maximal recovery of protein (see 
section 2.3.1). 
 
Figure 4.1 – SDS-PAGE gel comparing tissue grinding and sonication. 
Each lysis protocol was conducted using an equivalent weight of cell 
pellet. While specific bands are difficult to discern in both cases, more 
protein appears to be present in the soluble fraction of the sonication 
lysis samples, implying that the process of sonication liberates more 
protein than homogenisation. 
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4.3 Western blotting of transfected and 
untransfected cells 
4.3.1 Sample preparation 
To positively confirm that transfected HEK293S GnTI- cell were able to 
express Kv1.1, western blots were conducted on samples of cells stably 
transfected with pcDNA6 encoding the Kv1.1-TY10 construct, with blotting of 
untransfected cells conducted in parallel as a negative control. 
Both stably transfected and untransfected HEK293S GnTI- were grown in 
suspension (as described in section 2.2.2) in DMEM medium, supplemented 
with 10% FBS, 2.5% primatone and 0.02% pluronic acid (as described in 
section 3.5). Both transfected and untransfected cell cultures were 
supplemented with 5 mM sodium butyrate once their cell densities reached 
3×106 cells per ml and collected 48 hrs afterwards. 
0.5 g of cell pellet from both transfected and untransfected culture were lysed 
via direct dissolve in 1% DDM (see section 2.3.1.3). Direct dissolving of the 
cells was chosen to allow the whole contents of the cell, both in the membrane 
and soluble fraction to be screened. 
4.3.2 Comparison of western blotting using anti-GFP antibodies 
A western blot was conducted against DDM-dissolved transfected and 
untransfected HEK293S GnTI- cells. 20 µg of protein from both lysis solutions 
was applied to SDS-PAGE and the material was transferred to a nitrocellulose 
membrane for western blotting (see section 2.4.3 for details). Rabbit 
polyclonal anti-GFP antibody (FL) (Santa Cruz Biotechnology) diluted 1:200 
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in TBST was used as the secondary antibody. Binding of the secondary 
antibody was visualised using the BM Chemiluminescence Western Blotting 
Kit, as detailed in section 2.4.3 (Figure 4.2). 
 
 
Figure 4.2 – Post-transfer SDS-PAGE of whole cell contents of 
untransfected HEK 293S GnTI- cells and HEK 293S GnTI- cells 
expressing Kv1.1-TY10 (a) and chemiluminescent western blot of 
tranferred SDS-PAGE contents with polyclonal anti-GFP antibodies 
(b). Significantly higher signal is observed in the HEK 293S GnTI- 
stable cell line expressing Kv1.1-TY10. 
Kv1.1-TY10 (85 kDa) 
Fragment containing 
EYFP 
a) b) 
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The chemifluorescence observed in the sample of transfected cell lysate was 
substantially stronger than that seen in the untransfected cell lysate; a strong 
band correlating with a mass between 80 and 100 kDa was visible in the 
transfected lysate, but absent from the untransfected lysate; the mass of this 
band match the 85 kDa mass of Kv1.1-TY10 predicted by its amino acid 
sequence, strongly indicating that it is expressed in the transfected cells, with 
the antibodies binding to the GFP-derived EYFP tag. A further, dimmer band 
with a mass between 25 and 32 kDa. This may correspond to a separate 
EYFP molecule, possibly as a product of proteolysis of Kv1.1 or cleavage of 
the tag. 
The presence of less massive bands containing EYFP potentially indicates 
that there is some amount of instability of the construct. However, the less 
massive band correlating with EYFP appears visibly less intense than the 
Kv1.1-TY10 band, indicating that the full-length construct is more common 
than any degradation products. 
4.3.3 Comparison of western blotting using anti-Kv1.1 antibodies 
A further western blot was conducted against DDM-dissolved transfected and 
untransfected HEK293S GnTI- cells using rabbit polyclonal anti-Kv1.1 
antibody (A-15) (Santa Cruz Biotechnology) diluted 1:200 in TBST was used 
as the secondary antibody. 20 µg of protein from both lysis solutions was 
applied to SDS-PAGE and the material was transferred to a nitrocellulose 
membrane for western blotting (see section 2.4.3 for details). Binding of the 
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secondary antibody was visualised using the BM Chemiluminescence 
Western Blotting Kit, as detailed in section 2.4.3 (Figure 4.3). 
 
 
Figure 4.3 – Post-transfer SDS-PAGE of whole cell contents of 
untransfected HEK 293S GnTI- cells and HEK 293S GnTI- cells 
expressing Kv1.1-TY10 (a) and chemiluminescent western blot of 
tranferred SDS-PAGE contents with polyclonal anti-Kv1.1 antibodies 
(b). Significantly higher signal is observed in the HEK 293S GnTI- 
stable cell line expressing Kv1.1-TY10. 
Kv1.1-TY10 (85 kDa) 
Likely Kv1.1 (57 kDa) 
a) b) 
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Like the western blot using anti-GFP antibodies, the chemifluorescence 
observed in blotting of the transfected cell lysate with anti-Kv1.1 antibodies 
was substantially stronger than that seen in the untransfected cell lysate, with 
a strong band with a molecular weight between 80 and 100 kDa being visible 
in the transfected lysate and absent in the untransfected lysate sample. The 
molecular weight of this band of this band matches the 85 kDa mass of Kv1.1-
TY10 predicted by its amino acid sequence, which indicates that this band 
corresponds to the full-length construct. 
A slightly less intense band with a mass between 46 and 58 kDa was also 
observed in the transfected lysate sample. To a Kv1.1 molecule missing the 
C-terminal tag, as the molecular weight of the band corresponds to the 
predicted 57 kDa mass of a Kv1.1 monomer. This observation, like the lighter 
band seen in the anti-GFP western blot, seems to indicate some degree of 
cleavage of the protein, however it is not clear if any digestion of the protein 
is occurring prior to or subsequent to the solubilisation of the whole cell. 
It must also be noted that the ~57 kDa band has a potential equivalent in the 
untransfected cell lysate which is also displaying in the western blot. The band 
in the untransfected sample appears to be slightly less massive, though it is 
definitely of a similar size. This band may be the result of cross-contamination 
of sample, though the care was taken to avoid mixing of samples at each step. 
It is also possible that the band is unrelated to the transgenic expression of 
Kv1.1 and is an endogenously expressed protein in HEK293S GnTI- cells that 
is coincidentally binding the polyclonal antibody. A repeat of the western blot 
using specific monoclonal antibodies could be performed to test this 
hypothesis. 
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4.4 Extraction of membrane proteins and primary 
purification by IMAC 
The efficiency of protein extraction in DDM, SMA and DIBMA were compared 
through a combination of SDS-PAGE and UV spectroscopic measurement of 
protein concentrations. 800 mg of HEK 293S GnTI- Kv1.1-TY10 stable line VI 
cell pellet were used in each instance at the outset to ensure that the final 
results for each extraction method were directly comparable. 
Concentrations of DDM used for protein extraction was increased to 1% from 
the 0.1% concentration used in the previously discussed DDM/SDS 
comparison (see section 4.2). This modification was made in order to bring 
the protein preparation procedures into line with those used in earlier and 
contemporary research being conducted by other groups investigating cation 
channel structures (Nurani et al. 2008, Kintzer and Stroud 2016, 
Deivanayagabarathy et al. 2018). 
Fractions containing extracted Kv1.1 were loaded in parallel onto Novex Tris-
Glycine gels. As discussed in section 3.4, protein solubilised in SMA and 
DIBMA eluted from cobalt resin at 100 mM imidazole, while protein extracted 
in DDM eluted in the 250 mM imidazole fraction (Figure 4.4). 
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Figure 4.4 – SDS-PAGE of IMAC purified Kv1.1-TY10 extracted in 
DDM, SMA and DIBMA. Each method of extraction was applied to the 
same quantity of starting material, being 800 mg of cell pellet. Each 
lane contains the 250 mM imidazole elution fraction from IMAC 
purification. 
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The DDM-solubilised material displays the strongest band, with SMA and 
DIBMA-solubilised material displaying roughly equal quantities. Note that 
while some contamination is present in all 3 methods, the Kv1.1-TY10 band is 
significantly stronger than all other species present. This strongly suggests 
that extraction of protein by all 3 methods, coupled with primary purification by 
cobalt affinity purification via IMAC is sufficient to generate usable samples. 
4.5 Comparison of cobalt and nickel IMAC resin 
Comparison of Nickel and Cobalt-infused IMAC resins was conducted in order 
to determine which constituted the most effective option for the recovery of 
Kv1.1-TY10. Cells for this comparison were derived from suspension DMEM-
F12 culture stimulated with 5 mM sodium butyrate for 48 hrs, with protein 
extracted following the protocols discussed in section 2.3.2. 
To compare IMAC purification using cobalt and nickel-charged resins, two 
parallel experiments were conducted using 100 µl bed volume of pre-charged 
HisPur cobalt resin (Thermo Scientific) and sepharose resin (GE healthcare) 
charged with 10 column volumes of 100 mM NiSO4. These resins were then 
transferred to 5 ml columns with porous filters. The detergent solubilised 
protein mixture was then split in half and purification of both halves carried out 
on either column. The dialysed protein fractions were concentrated on a 100 
kDa cut-off membrane and loaded onto a pre-cast Novex 4-12% Bis-Tris gel 
for SDS-PAGE (Figure 4.5).  
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Figure 4.5 – SDS-PAGE comparing the binding and elution of proteins 
in DDM-solubilised membranes derived from stably transfected HEK 
293S GnTI- cells expressing Kv1.1-TY10 on nickel-charged sepharose 
and cobalt-charged HisPur resins. Bands whose mass correspond to 
the predicted 85 kDa mass of the tagged Kv1.1 construct have been 
labelled with green boxes. 
 
The resulting gel from testing different purification resins (Figure 4.3) indicated 
stronger binding of Kv1.1-TY10 by the cobalt-charged HisPur resin, 
corresponding to a stronger band between 80 and 100 kDa appearing in the 
250 mM imidazole elution of that resin when compared to the nickel-charged 
sepharose. 
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4.6 Äkta Explorer purification and size-exclusion 
chromatography  
4.6.1 Äkta Explorer-based IMAC 
DDM-solubilised Kv1.1-TY10 was subjected to IMAC purification through the 
HisTRAP column method detailed in section 2.3.3.3. The A and B buffers were 
supplemented with 0.02% (w/v) DDM to maintain the detergent micelle 
surrounding the protein. Once the programmed imidazole gradient had 
concluded, 10 µl samples of the first 96 elutions were transferred to a 96-well 
microplate and analysed using a FluoSTAR OPTIMA microplate reader (BMG 
Biotech). The in-built GFP fluorescence intensity program was then used to 
measure the fluorescence of each elution fraction (Figure 4.6). 
The fluorescence measured in the elution fractions revealed a distinct peak 
between 11.1 ml and 13.35 ml. This indicated that the EYFP-tagged protein 
was eluting predominantly within these fractions. Based on this, the 15 elution 
fractions corresponding to this peak were pooled together to form a 2.25 ml 
solution that was taken forward to SEC for secondary purification, as detailed 
in the next section.  
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Figure 4.6 – Fluorescence of elution fractions collected from 1 ml 
HisTRAP column during Kv1.1-TY10 purification. The peak in recorded 
fluorescence between 11.1 ml and 13.35 ml, highlighted in red, were 
interpreted to correspond to Kv1.1-TY10 and retained for secondary 
purification via SEC. 
4.6.2 Äkta Explorer-based SEC 
SEC purification of the HisTRAP purified Kv1.1-TY10 discussed in the 
previous section was conducted in accordance with the method detailed in 
section 2.3.4. Like the IMAC step previously, the running buffer was 
supplemented with 0.02% (w/v) DDM to prevent denaturation of the protein. 
Also, in line with the previous step, fluorescence from each elution fraction 
was recorded using the GFP fluorescence intensity program of the FluoSTAR 
OPTIMA (Figure 4.7). 
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Figure 4.7 – Graphs detailing the fluorescence recorded for each 0.15 
ml fraction eluted from SEC purification on Superdex 200 column. 
The fluorescence observed in the elutions from this purification were weaker 
than the IMAC purification, as no substantial peak was observed in any elution 
fraction. While individual minor peaks are discernible, none extend 
significantly higher than the average of 695 mAU. This strongly suggests that 
any protein samples loaded onto the column did not elute from the column in 
the fractions that were screened. 
The protein may have been lost during the purification process if the sample 
had eluted during the early washing steps prior to the collection of elution 
fractions. In future, it would be sensible to collect the flow-through of the initial 
if the protocol is ever repeated so that the sample could be analysed either by 
UV absorabance, fluorescence measurement or western to check for the 
presence of Kv1.1-TY10. 
4.7 Mass spectrometry 
Mass spectrometry protein identification was used to determine the identities 
of contaminants found in some of the lanes seen on SDS-PAGE, as well as 
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add further evidence to support the claim that the prominent band often 
observed between 80 and 100 kDa in 250 mM elution lanes is Kv1.1-TY10. 
SDS-PAGE was conducted with 100 mM imidazole elution from IMAC 
purification derived from FreeStyle 293 cultured cells and 250mM imidazole 
elution derived from EX-CELL cultured cells. These samples were selected as 
they had the most prominent bands. The gel was given to Dr. Rachel George 
of the Mass Spectrometry facility, who determined which bands were suitably 
prominent to allow collection and analysis (Figure 4.8). 
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Figure 4.8 – SDS-PAGE submitted for mass spec analysis. The 
FreeStyle 250 mM imidazole preparation was selected as is appeared 
to contain the most prominent selection of contaminants. Likewise, the 
EX-CELL 250 mM imidazole elution fraction was also submitted as it 
was judged to have the most prominent band corresponding to the 
species suspected to be Kv1.1. Each collected band has been 
annotated using an arrow and an identifying label. Band B1 was 
strongly suspected to correspond to Kv1.1-TY10, based on its predicted 
mass of 85.8 kDa. 
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Protein identification provided insights into the identity of some of the selected 
bands. Analysis of band B1 provided the most evidence relating to the identity 
of the band corresponding to expected mass of Kv1.1-TY10 had been correctly 
identified, as 45 fragments returned during analysis displayed a 100% 
sequence identity with Kv1.1, covering 54% of the protein sequence (Figure 
4.5). Protein identification also revealed 13 fragments with 100% identity with 
Kv1.3, corresponding to 26% coverage of Kv1.3 (Figure 4.9). 
The Kv1.3 observed in the mass spec samples had 100% sequence identity 
with the human Kv1.3. This may suggest that the purified Kv1.1 co-purified with 
Kv1.3, perhaps as part of a heteromeric complex. However, only 1 fragment 
was unique to Kv1.3, with all other overlapping with Kv1.1 (Figure 4.10). 
However, it is important to note that deamination of the glutamate to a 
glutamine would also result in the same mass of the fragment. Therefore, it is 
more likely that the fragment represents a fragment of Kv1.1 with a 
deaminated E121 residue, rather than the Q188 residue of Kv1.3 (Figure 
4.11).  This conclusion is further validated by the fact that no other fragments 
unique to Kv1.3 were identified.  
Other bands submitted for protein identification did not return reliable data, 
with most signals being overpowered by keratin contamination (see Appendix 
8.2 for details). Some evidence was found for heat shock proteins, however, 
with the band immediately below Kv1.1 in the 250 mM imidazole elution 
fraction corresponding with low sequence identity to the protein Hsp70. Had 
the contaminants been identified it may have provided a means of reducing 
their presence through gene silencing or alternative purification approaches.
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Figure 4.9 – Schematic diagram displaying peptides detected in band  B1 by mass spectrometry (blue lines) which align with 
sequence of Kv1.1. Identified sites of post-translational modification (carbamidomethylation, deamidation and oxidation) are also 
highlighted. 
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Figure 4.10 – Schematic diagram displaying peptides detected in band B1 by mass spectrometry (blue lines) which align with 
Kv1.3. Identified sites of post-translational modification (carbamidomethylation, deamidation and oxidation) are also highlighted. 
Note the deamination of residue 188, identified by ProteinLynx Global Server as being a deaminated glutamine.
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Figure 4.11 – Sequences of Kv1.1 and Kv1.3 colour coded according to fragments identified in mass spectrometry. Green 
indicates fragments which align with both proteins, yellow indicates fragments unique to KCNA1 and red indicates a glutamate 
residue which is misrepresented as glutamine in KCNA3 due to incorrect detection of deamination at the residue by the software 
(see Figure 4.8 for original output data). 
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4.8 TEV cleavage 
Cleavage of cobalt resin IMAC purified Kv1.1-TY10 was carried out in the first 
instance using ProTEV Plus (Promega) following the manufacturer’s 
instructions (see section 2.4.4) and the incubated aliquots were subjected to 
SDS-PAGE to check for the effectiveness of cutting between each duration of 
incubation. The gel revealed a disappearance in the band corresponding to 
Kv1.1 after only 1 hr of incubation (Figure 4.12).  
In light of the above result, a further reaction was carried out to positively 
identify product bands from the digestion. The second reaction was conducted 
with the dilution by water in the manufacturer’s protocol excluded. This was 
done to keep the sample in a small volume and allow more to be loaded for 
SDS-PAGE.  10 µg mass of protein from the initial protocol was retained, with 
the volume of ProTEV buffer and 100 mM DDT adjusted down to 0.4 µl and 
0.2 µl respectively to retain the same final concentration. The sample was split 
into 2 × 5 µg aliquots, with 5 units ProTEV added to one, but excluded from 
the other as a negative control. A third 10 µl reaction mixture was also made 
with 5 units of ProTEV, 1 mM DDT and 1 dilute ProTEV buffer was made as 
a further negative control to check the protein contents of the ProTEV enzyme 
alone. All 3 were then incubated at 30 C for one hour. 
All 3 mixtures were subjected to SDS-PAGE and the gel transferred onto 
nitrocellulose. The nitrocellulose membrane was then western blotted with 
anti-GFP antibody. This would allow the fragments containing EFYP 
generated by cleavage fragments to be identified (Figure 4.13).  
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Figure 4.12 – SDS-PAGE of TEV cleavage incubation products. Each 
product lane features a reaction conducted for a different length of time, 
along with a 0 hrs incubation as a negative control. 
The band observed in the 0 hrs negative control lane corresponds to the 
Kv1.1-TY10 protein which is the target of cleavage. This band is not seen 
following 1 hr of incubation, indicating digestion of the protein early during the 
course of incubation. 
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Figure 4.13 – SDS-PAGE and western blot detailing TEV protease 
digestion of Kv1.1-TY10 protein. Bands corresponding to Kv1.1-TY10 
have been outlined in green, ProTEV protease has been outlined in 
blue and the EYFP fragment generated post-digestion has been 
outlined in red. 
The molecular weights of the fragments were predicted by the online 
ProtParam tool as part of the ExPASy server, based on the amino acid 
sequence of the Kv1.1-TY10 construct (Gasteiger et al. 2005). The predicted 
fragments for the N-terminal fragment containing Kv1.1 and the C-terminal 
fragment containing EYFP and His10 had masses of 57.5 kDa and 28.3 kDa, 
respectively. 
A species with a molecular weight corresponding to the predicted weight of 
the C-terminal cleavage product containing EYFP is visible in the western blot 
and is annotated in red in Figure 4.13. The absence of this species in either 
negative control strongly indicates cleavage of the protein at the TEV cut site. 
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The disappearance of Kv1.1-TY10 over time during incubation as seen in 
Figure 4.12, further corroborates this. 
This initial result proved difficult to implement into plans for reverse purification 
on digested protein on IMAC, however, as the product bands appeared to be 
extremely faint. Attempts to reverse purify the protein produced no visible 
results on SDS-PAGE, nor was significant quantities of protein detectable via 
UV spectrometry. 
Later digestion trials attempted to avert loss of protein by reducing the 
digestion temperature from the recommended 30C to 4C to avoid 
degradation linked to temperature. Trials were also conducted with DTT 
reagent excluded in case of protein loss by oxidative degradation, however 
neither of these modifications to the protocol increased yields of protein. 
Inspection of sequencing data of the pcDNA6 plasmid encoding the construct 
confirmed that the TEV cleavage site was intact. The lack of observed 
cleavage in later trials may therefore be due to obstruction of the site. 
4.9 Circular dichroism 
4.9.1 Spectrum and Dichroweb analysis 
To determine that purified Kv1.1-TY10 was correctly folded, the protein was 
subjected to CD spectroscopy which can give the composition of the protein. 
The initial buffer used in CD featured 150 mM sodium chloride. It was later 
realised that chloride ions are known to interfere significantly with protein 
studies in CD, as they are known to strongly absorb at wavelengths shorter 
than 195 nm (Kelly et al. 2005). While this did not impinge on the wavelengths 
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relating to α helical and β sheet elements, it did obscure sections of spectra 
which provide information on the presence of coils in the protein structure. As 
such, the buffer was redesigned in order to use potassium fluoride (KF) in 
place of sodium chloride, as fluoride ions do not have the same absorbance 
characteristics as chloride. 
CD spectra of Kv1.1-TY10 in 0.02% DDM was recorded across a range of 
wavelengths from 180-260 nm at 20 C. The protein was then split into 2 equal 
amounts, with one frozen gradually at -20 C and the other flash-frozen in 
liquid nitrogen, then later thawed and CD analysis repeated (Figure 4.14). This 
would allow the effects of different methods freezing on protein folding and 
stability to better inform how to handle and store samples between 
experiments. 
The spectrum that was recorded displayed a profile which was consistent with 
a predominantly alpha-helical protein, which was expected based on 
homology models of Kv1.1. These spectra were analysed using the online 
Dichroweb server. The data was analysed using the CONTIN programme and 
returned a result of ~55% alpha-helical, ~16% beta sheet and ~9% coiled, with 
the remaining 20% believed to be disordered. This result broadly matches the 
projected make-up of the construct, as Kv1.1 is ~80% alpha-helical, with the 
beta sheet component coming from the EYFP tag. 
The troughs of in the spectra of protein samples frozen by either method are 
noticeably less than that seen in the unfrozen samples. This indicates that 
there is less secondary structure of the frozen sample than the unfrozen 
sample. Such a finding is not surprising as freezing of protein samples is 
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known to disrupt the folding of protein molecules (Wolkers et al. 2007). More 
absorbance is visible in protein samples frozen by liquid nitrogen compared 
to samples frozen by refrigeration at -20 °C, indicating that storage of samples 
by freezing in liquid nitrogen preserves more of the protein secondary 
structure. 
 
 
Figure 4.14 – CD spectra of Kv1.1-TY10 in 150 mM NaCl, 50 mM Tris, 
10 mM KCl pH 7.4 across 180-260 nm wavelengths. This 
representative plot contains the troughs in the molar elipticity at 214 nm 
and 222 nm, which are characteristic of alpha-helical secondary 
structure in analysed proteins. Later experiments replaced NaCl with 
NaF to avoid disruption caused though absorbance by chloride ions. 
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4.8.2 CD measurement of protein stability in temperature ramp 
Temperature ramps were employed in conjunction with CD to investigate the 
inherent stability of Kv1.1, as well as the difference in its stability when 
extracted into DDM, SMA and DIBMA. Initial experiments with temperature 
ramping and CD were conducted using the in-house Chirascan Plus system 
at the University of Leeds, which was programmed detailed in section 2.4.6.2. 
Temperature ramps were conducted using freshly purified DDM, SMA and 
DIBMA extracted protein (Figures 4.13, 4.14 and 4.15, respectively). At lower 
temperatures, DDM-extracted Kv1.1-TY10 displayed a curve typical of α 
helical proteins, as expected, with peaks at 214 nm and 222 nm flattening out 
as the temperature increased, indicating that the increase in temperature had 
triggered unfolding of the secondary structure. 
While a consistent curve was observed for DDM-extracted protein, SMA and 
DIBMA displayed a less regular, jagged profile, indicating interference of the 
signal by the polymer. An α-helical profile could be broadly discerned in all 3 
spectra, with flattening of the 222 nm and 214 nm peaks also visible, no 
concrete conclusions could be made.
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Figure 4.15 – Graph of CD spectra of fresh Kv1.1-TY10 recovered in DDM, with the profile at ramping temperatures. Each plotted 
line represents the spectra of the protein at temperatures between 25°C and 99°C, coloured from light pink to maroon. 
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Figure 4.16 – Graph of CD spectra of fresh Kv1.1-TY10 recovered in SMA, with the profile at ramping temperatures. Each plotted 
line represents the spectra of the protein at temperatures between 25°C and 99°C, coloured from light green to dark green. 
-1
-0.5
0
0.5
1
1.5
195 205 215 225 235 245 255
E
li
p
ic
it
y
 (
m
il
li
d
e
g
re
e
s
)
Wavelength (nm)
25 26 27 28 29 30 31 32 33 34 35 36 37 38 39
40 41 42 43 44 45 46 47 48 49 50 51 52 53 54
55 56 57 58 59 60 61 62 63 64 65 66 67 68 69
70 71 72 73 74 75 76 77 78 79 80 81 82 83 84
85 86 87 88 89 90 91 92 93 94 95 96 97 98 99
126 
 
 
Figure 4.17 – Graph of CD spectra of fresh Kv1.1-TY10 recovered in DIBMA, with the profile at ramping temperatures. Each 
plotted line represents the spectra of the protein at temperatures between 25°C and 99°C, coloured from light blue to dark blue. 
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DDM-extracted sample displayed the strongest absorption, with ellipicity 
reaching values approaching -5 millidegrees for 222 mm wavelength at 25 °C. 
Both SMA and DIBMA-extracted samples displayed less absorbance, with 
ellipicity reaching only -0.55 and -1.5 millidegrees, respectively. This may 
have been a result of interference by the polymers; the jagged-irregular 
appearance of the SMA and DIBMA-extracted sample data also appears to 
indicate some interference in the absorption which is obscuring the protein CD 
spectrum. 
As the data for SMA and DIBMA-extracted protein displayed irregularities, the 
program was redesigned to take readings in triplicate at each time point rather 
than in singular, with a view to produce more regular, averaged readings. 
However, this new program proved to have a series of problems which had 
not initially been recognised. The time required to ramp the temperature to 
single incremental degrees and allow time to settle resulted in an 
unrealistically long cycle, as recording absorbances of 5 samples at 75 
different temperature points ranging from 25°C to 99°C, with each 
measurement taken in triplicate, required over 72 hrs to complete. This 
extended time investment caused a number of issues, most prominently the 
unreliability of data due to the inability to account for temporally promoted 
degradation independent of the temperature 
Faced with these shortcomings in the initial experimental design, advice was 
sought from collaborators in the Dafforn group at the University of 
Birmingham, who lent their experience in analysing membrane protein stability 
and the use of their JASCO J-810 Spectropolarometer (see Graph 4.7). On 
their advice, the wavelength of recorded absorbance was limited only to 222 
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nm, firstly on the basis that recording at a limited number of wavelengths 
would speed up the process and significantly reduce the effects of time-based 
degradation on recorded absorbances. Secondly as the presence of DDM, 
SMA and DIBMA are all known to absorb light wavelengths between 220 nm 
and 180 nm, leaving 222 nm the only wavelength associated with secondary 
structure information that is not disrupted by their presence. 
 
Figure 4.18 – Graph plotting the elipicity of Kv1.1-TY10 at 222 nm in 
DDM, SMA and DIBMA across an increasing temperature. 
The ellipicity at 222 nm for protein in DDM and SMA is similar, while the 
DIBMA spectrum remains at a shallow incline across the entire range of 
temperatures. 
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4.10 SEC-MALS 
SEC-MALS analysis of DDM-solubilised Kv1.1-TY10 was conducted as 
detailed in section 2.4.4. SEC was conducted over a time scale of 30 min 
(Figure 4.19). The first peak on the UV spectrum (elution time 8 minutes) was 
determined to correspond to the folded protein, as the subsequent peak at 10 
minutes displayed high light scattering and UV absorption, which is typical of 
empty detergent micelles (Sahin and Roberts 2012).  
The hydrodynamic radius determined from this data indicated a maximum 
radius of ~4.7 nm from peak 1, or ~16 nm for peak 2. While neither of these 
matches the anticipated radius of the channel complex, which in reality would 
be ~6 nm, it is worth noting that MALS is incapable of distinguishing between 
protein and detergent, meaning that the lipid belt surrounding the protein can 
skew the result away from the predicted values. 
The molecular mass calculated from the MALS data did not match the 340 
kDa mass which was predicted for a tagged tetramer. The weights are close 
to the predicted mass of the untagged tetramer (232 kDa). However as the 
tag had not been cleaved beforehand, due to the previously documented 
difficulties with TEV digestion, such a species is unlikely to be present. As 
such, the results for molecular mass calculation are also inconclusive. 
Overall, SEC-MALS was unable to provide a robust description of the Kv1.1-
TY10 protein, likely due to the limitations of both the MALS technique, as well 
as interference from detergent and the EYFP tag. 
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Figure 4.19 – Graph of SEC-MALS data from DDM-solubilised Kv1.1-
TY10. Light scattering (LS), UV absorbance, difference in refractive 
index (dRI) and quasi-elastic light scattering (QELS) of Kv1.1-TY10 
extracted in DDM are plotted as a function of time as elution fractions 
leave the column. LS and QELS are highly similar, with QELS being 
difficult to observe beneath LS. Peaks 1 and 2, as represented by red 
and blue dotted lines respectively around the 8 min peak, were the 
narrow and broad sections of the peak sections of the peak that was 
analysed for hydrodynamic radius and molecular mass. 
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5 Structural analysis of homotetrameric Kv1.1 
5.1 Background 
Electron microscopy is a rapid evolving field, with recent advances allowing 
cryo-EM to make significant strides in the development of atomic resolution 
structures (Rawson et al. 2016). Membrane proteins have not been excluded 
from this revolution, with many larger membrane protein complexes, such a 
PIEZO1, being determined to atomic resolution (Ge et al. 2015). With the 
recent construction and activation of the Astbury Biostructure Laboratory 
(ABSL) on-site at the Faculty of Biological Sciences, cryo-EM was a natural fit 
for this project in its goal to investigate the structure of Kv1.1 and its 
interactions with membrane scaffolds and inhibitors. 
Specimens of single particles negatively stained with uranyl acetate was used 
for preliminary structural investigations. While negative stain electron 
microscopy is unable to provide the atomic resolution necessary to investigate 
the specific interactions between a protein and smaller drug molecules, it is 
possible for it to resolve flexibility in structure, as well as interactions with other 
molecules, such as associated proteins (subunits, toxins, etc.) and lipid 
nanodiscs (Burgess et al. 2004, Akkaladevi et al. 2013). Additionally, 
micrographs of proteins in negative stain can also allow the quality of samples, 
such as the presence of aggregation and the homogeneity of sample, to be 
inspected relatively quickly, making it an excellent technique for screening 
samples (Zhang, L. et al. 2013).  
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5.2 Negative stain electron microscopy 
5.2.1 Grid optimisation 
Samples of Kv1.1-TY10 purified via IMAC were taken forward to structural 
study via negative stain electron microscopy. The presence of both EYFP tag 
of Kv1.1-TY10, as well as DDM or SMA/DIBMA in prepared samples made it 
difficult to accurately determine concentrations of protein. This created a 
challenge for the production of negative stain grids, as an accurate 
concentration helps to determine sensible dilutions of the protein ahead of grid 
production. This was addressed by creating a series of dilutions for each 
sample, ranging ×10, ×25, ×50 and ×100 diluted, using filter sterilised dialysis 
buffer from the dialysis step following IMAC purification. 
Each diluted sample was then applied to a negative stain grid and the density 
and quality of protein in each was assessed visually in EM. The quantity of 
protein was investigated through visual analysis of particles under negative 
stain. If micrographs displayed particles too densely packed to be easily 
differentiated, the dilution of sample was deemed to be too high. Further 
dilutions of up to ×250 and ×500 were made if grids with ×100 dilute protein 
were found to have excessively high concentrations of protein. Protein quality 
was assessed on a case-by-case basis, with features such as large, irregular 
structures used as indicators of protein aggregation and the predominance of 
small, regular particles used as indicators of better-quality samples.  
Grids were made using Kv1.1-TY10 extracted in DDM, SMA and DIBMA and 
assessed visually to gauge their individual suitability to negative stain. Both 
DDM and SMA extracted materials generally displayed consistently sized 
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particles with little sign of aggregation. As such DDM and SMA extracted 
sample were suitable for collection of data, as detailed in section 5.2.2. Grids 
featuring DIBMA extracted Kv1.1 predominantly displayed large, globular 
species typical of aggregated protein. 
In the first instance, screening of negative stain grids was conducted on a T12 
electron microscope (FEI) using a Gatan CCD camera. Grids were screened 
and evaluated on a number of properties, including: depth of grid staining 
deep enough to provide contrast, but light enough to preserve detail; particles 
being separated and easy to discern individually (i.e. monodispersed); finally, 
particles displaying consistency in size and overall shape. 
5.2.2 Data collection 
Data was collected on samples of IMAC-purified Kv1.1-TY10; initial data 
collection was conducted using DDM-solubilised samples. The views obtained 
from the first batch of grids, generated through 20× dilution onto the grid 
surface and coated with 1% uranyl acetate, displayed high density, though 
particles were sufficiently monodispersed to allow individual particles to be 
discerned (Figure 5.1a). Most of the observed particles displayed similar 
dimensions, with acceptable levels of staining. A dataset of 140 micrographs 
was collected at 30,000 × magnification for processing on a Technai T12 
microscope operating at 120Kv. 2307 particles were manually selected from 
a subset of 90 micrographs; these particles were then sorted by their 
appearance into classes, with each class representing a particular view of the 
molecule, which were then averaged to produce a consensus image of the 
particular class (Figure 5.1b). 
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Figure 5.1 – Example of negative stain micrograph from Kv1.1-TY10 
extracted in DDM and coated in 1% uranyl acetate (a) and class 
averages produced from processing of selected particles (b).  
a) 
b) 
100 nm 
50 nm 
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Later negative stain data sets were collected on the in-house F20 microscope 
(FEI) using a CMOS detector. This set up permitted larger micrographs to be 
recorded (due to the increase in camera size), with higher magnifications 
possible, due to increased microscope stability. The data were processed in 
RELION to look for differences based on new developments in algorithms, in 
particular the maximum likelihood procedures that better estimates the noise 
in the images (Rawson et al. 2016). Although multiple negative stain data sets 
were collected to assess protein quality, only a few representative examples 
are presented here.  
5.2.3 Data processing 
5.2.3.1 DDM-solubilised Kv1.1-TEV-EYFP-His10 
An electron density map based on images of purified Kv1.1 collected using the 
T12 microscope was generated using the program IMAGIC to classify 
particles and EMAN2 to generate an initial 3D reconstruction. The resulting 
reconstruction was generated using the standard 3D reconstruction procedure 
of projection mapping and particle assignment (Tang, G. et al. 2007). 2307 
manually selected particles were used for structure generation. 
To generate the model both 4-fold (C4) and no symmetry (C1) were applied 
with the 4-fold symmetric processed data; regardless of the imposition of 
symmetry, the C1 data still displayed 4-fold symmetric properties (Figure 5.2). 
The homology model of Kv1.1 based on the Kv1.2-Kv2.1 chimera produced by 
Phyre2 was fitted into the EM map using the default Chimera map fitting tool. 
and appears to fit very well into the global shape of the structure (Pettersen et 
al. 2004, Kelley et al. 2015). 
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Figure 5.2 – Negative stain EM structure produced from processing of 
micrograph dataset of DDM-solubilised Kv1.1-TY10. Electron density 
from data processing is represented in grey. A cartoon representation 
of a Kv1.1 homology model generated by Phyre2 from the Rattus 
norvegicus Kv1.2-2.1 chimera structure, represented in pink, has been 
fitted into the density map (Banerjee et al. 2013, Kelley et al. 2015). 
 
The Kv1.1 homology model and the electron density map seen fitted in Figure 
5.2 match strongly, indicating that the particles selected in the micrographs 
and classes subsequently picked belong to Kv1.1-TY10. No density relating to 
the C-terminal EYFP can be seen in the electron density, however. This is 
likely a result of class averaging removing flexible elements, as the linker 
connecting the C-terminal tags is unstructured and likely to allow the EYFP 
domain to move freely. 
50 Å 
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5.2.3.2 SMA-solubilised Kv1.1-TEV-EYFP-His10 
Negative stain analysis of samples was also used as a method to visually 
assess Kv1.1-TY10 samples to check for signs of aggregation or 
degradation.  Particles for the production of a model of the channel 
complex in SMA were picked manually in the EMAN2 Boxer program. 9909 
particles were picked across all 140 micrographs. Particles were 
processed to produce two separate data stacks: one comprised all 9909 
particles, and a second consisting of a subset of 6786 particles which were 
inspected visually to have the highest detail of particles and lowest 
background noise. Models were generated from both sets without 
imposing symmetry. Unlike the model determined from DDM-solubilised 
sample, the models were incomplete, showing inconsistency in the sizes 
of different domains, with large holes in the channel. 
C4 symmetry was then applied in a second processing run of both particle 
stacks. This adjustment resulted in structure which more accurately 
resembled the predicted structure of Kv1.1. The model best resembling the 
homology model was produced from the particle stack composed of the 
6786 particles partitioned from the complete set (Figure 5.3). Although the 
resulting model appeared consistent with the anticipated structure of the 
complex, the imposition of 4-fold symmetry may have introduced bias into 
the resulting map. 
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Figure 5.3 – Cartoon representation of map generated from negative 
stain data of SMA-solubilised Kv1.1-TY10. A top-down view is 
represented on the left, with a 90° rotation to a side view on the right. 
A homology model generated from the sequence of Kv1.1 using the 
Phyre2 server has been fitted into the interior of the map to illustrate its 
resemblance to the predicted structure. 
 
5.2.3.3 DIBMA-solubilised Kv1.1-TEV-EYFP-His10 
A dataset of micrographs was collected from grids produced using DIBMA-
solubilised samples of Kv1.1-TY10. The protein displayed signs of 
aggregation and unfolding, with few distinct particles visible on the grid. As 
a result, selection of particles for processing was difficult and ultimately too 
few were available to make processing of data viable. 
In order for DIBMA to be used consistently for future structural studies and 
characterisations, the polymer must be able to extract proteins in a folded, 
stable state. The initial data from negative stain does not indicate this to 
be the case, although further optimisation and study will be required to fully 
discount DIBMA. 
50 Å 
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5.3 Cryo-electron microscopy 
5.3.1 Grid preparation 
After initial negative stain analysis, along with the low-resolution structures 
obtained, there was sufficient confidence in the quality and stability of DDM 
and SMA-extracted samples to move forwards to cryo-EM. DIBMA-extracted 
samples were also analysed in some instances to ensure that issues with 
protein stability were not a result of negative stain sample preparation 
practices. 
In the first instance, a range of different grid types were tested (see Table 2.7 
for details). Graphene oxide grids of SMA-solubilised sample were prepared 
using the Leica EM GP with the standard program employed by Dr. Stephen 
Muench. Grids were prepared in pairs at concentrations of 3 and 4-fold dilution 
from the IMAC-purified sample. These grids were stored in liquid nitrogen 
ready for later analysis. 
5.3.2 Grid Screening 
Initial screen was performed in-house using the F20 microscope fitted with a 
CCD camera, which at the time had poorer signal-to-noise than a direct 
detector. Moreover, all images were collected manually in low-dose mode, 
which combined with difficulties in grid loading caused a low throughput and 
a shortage of data for analysis. Screening of grids later moved to the ABSL 
on Krios microscopes 1 and 2. This allowed for more rapid screening of grids 
and access to means for more rapid data collection. 
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Unfortunately, many of the screening images taken in-house during the early 
stages of the ABSL electron microscopy facility operation was lost as a result 
of file corruptions and selection of incorrect formats for saving, which impeded 
optimisation of grid conditions.  
5.3.3 Data collection and processing 
SMALP-solubilised protein was taken forward to cryo-EM analysis on the F20 
microscope in Leeds with the assistance of Dr. Rebecca Thompson. 10, 20 
and 50-fold dilutions were created and examined on the microscope. It was 
determined that 20-fold dilute samples were best for analysis (Figure 5.4). 
These grids were submitted to Diamond, where 3000 micrographs were taken 
on a Titan Krios fitted with a K2 direct electron detector. 
The micrographs displayed a number of discrete particles, although there 
were signs of ethane ice contamination, likely as a result of errors in grid 
preparation or grid storage. This may have been a result of low salt 
concentrations causing SMA polymer to stick together and to the his-tags of 
the proteins. Particle selection was carried out on a subset of 100 micrographs 
and class averaging was conducted by Shaun Rawson (Figure 5.5). No 
suitable classes could be produced however and no means of autopicking 
particles computationally could be determined. Given the poor quality of the 
resulting classes, particularly given the low signal-to-noise visible in the 
images, it did not seem justifiable to further process the data. 
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Figure 5.4 – Representative image of micrographs taken of SMA-
solubilised sample screened at the Diamond Synchrotron electron 
microscopy facility. Grid screening and micrograph collection was 
conducted on Titan Krios electron microscopes. Examples of possible 
protein particles have been circled in black. The quality of sample on 
the grid was poor, with ethane and non-vitreous water ice 
contamination, as annotated. 
  
500 nm 
Ethane ice 
contamination 
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Figure 5.5 – Classes generated with (a) and without a reference model 
(b and c) from autopicked cryo-EM data of SMA-solubilised sample. 
Class averages which display more defined shape have been outlined 
in green. 
  
b) c) 
a) 
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Classes generated without a reference model (a) do not show any features of 
note. Classes generated with homology model used as reference (b and c) 
show slightly more consistency, with some potential, however these were in 
the minority, indicating that the dataset was not of sufficient quality to justify 
further processing.  
5.4 Negative stain EM of Kv1.1 co-incubation with α-
DTX 
A number of EM studies have used small molecule inhibitors to stabilise 
membrane protein complexes.  In addition to being more stable it can also 
inform on small molecule binding.  Therefore, to try and improve the quality of 
the resulting reconstruction, Kv1.1 was studied in the presence of a-DTX. 
Kv1.1-TY10 was recovered from stably transfect HEK 293S GnTI- cells grown 
in adherent culture. Protein recovery was carried out using DDM following the 
protocol detailed in section 2.3.2. The concentration of protein was determined 
to be 0.5 mg/ml through 260 nm absorbance using the DS11 nanodrop. α-
DTX, supplied as a 1 µM stock in PBS, was diluted to 10 nM through a 10x 
dilution into dialysis buffer. 27 µl of Kv1.1 was applied to 3 µl of 10 nM toxin to 
produce a final concentration of 1 nM. This was then taken forward to negative 
stain electron microscopy, with a 25-fold dilution tested, however the 
micrographs proved to have poor background, which was believed to have 
resulted from an excess of α-DTX in the solution, leading to issues with 
staining. 
An alternative strategy was developed to remove excess α-DTX from the 
solution prior to staining. The concentration of α-DTX was reduced 10-fold and 
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excess toxin was removed through dialysis in 6-8 kDa cut-off GeBAflex tubes 
(Scienova); this cut-off limit was selected as it most closely matched the 7 kDa 
molecular weight of α-DTX (Tytgat et al. 1995). Dialysis was repeated 3 times, 
with samples recovered after each step. Each dialysis step lasted 10-15 
minutes. The 3rd dialysis sample was tested first through negative stain 
electron microscopy of a 2-fold diluted sample (Figure 5.6). 
 
 
Figure 5.6 – Representative micrograph of DDM-solubilised Kv1.1-
TY10 co-incubated with α-DTX. The grid displays poor signal-to-noise 
with an inconsistent background. This is likely due to excessive 
quantities of toxin molecules, which due to its peptidic nature will also 
be stained by the uranyl acetate. 
 
  
100 nm 
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While the quality of the micrograph, shown in Figure 5.7, proved to be a 
substantial improvement over the initial attempt, the micrograph appeared to 
be over-populated. A further grid was created a 3-fold dilution of the sample 
to reduce the density of particles (Figure 5.7). 
 
 
Figure 5.7 – Representative micrograph of diluted Kv1.1-TY10 co-
incubated with dendrotoxin-α. This grid displays improved background 
over Figure 5.7, with particles more easily discernible from the 
background. Examples of particles which display good contrast with the 
background, defined edges and sufficient distance from other particles 
have been outlined. 
 
  
100 nm 
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The quality of the observed micrograph in Figure 5.8 images was deemed of 
high enough warrant the collection of a data series – in total, 132 micrograph 
images were collected for processing. This improvement is likely a result of 
dilution of the peptide toxin, resulting in lower staining of the grid. No class 
averages could be generated from the collected particles using EMAN2, with 
no distinct shapes identified in the processed data. This might have been the 
result of excessive background making the edges of particles more difficult to 
determine with consistently, leading to particles becoming more difficult to 
classify. 
Two cryo-electron microscopy grids were generated using undiluted 0.5 
mg/ml Kv1.1 using the Leica EM GP automatic plunge freezer. 2 further grids 
were also made using the 3rd dialysis sample used in the successful negative 
stain trial above. These grids were placed into storage in liquid nitrogen for 
later analysis. However, due to the poor quality in the previously analysed 
negative stain data and limited time remaining in the final year of the project, 
it was not deemed worthwhile to screen these grids.
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6 Discussion 
6.1 Expression of Kv proteins in HEK cell culture 
6.1.1 Construct production 
Sanger sequencing of the plasmids extracted from transformed bacterial cells 
confirmed that the desired modifications had been made in the cases of Kv1.1-
EYFP-His6, Kv1.1-TEV-EYFP-His6 and Kv1.1-TY10. The native KCNAB2 gene 
was also successfully cloned out of foetal brain cDNA and inserted into 
pcDNA3.1, with a modified KCNAB2-cMyc-His6 plasmid made later on. The 
fluorescence observed following transfection with the EYFP-tagged Kv1.1 
constructs confirmed that the constructs carried by plasmids had been 
expressed, however such a result only confirmed that the fluorescent tag had 
been expressed and correctly folded. 
Later assessment of purified protein via CD spectroscopy indicated that the 
protein displayed a secondary structure profile matching that expected of 
Kv1.1-TY10, corroborating that the protein was correctly folded. Mass 
spectrometry also positively confirmed that the protein had been 
overexpressed in the transgenic cell line. Negative stain EM of extracted 
protein produced an electron potential map resembling the expected structure 
of Kv1.1, indicating that a tetrameric channel was formed. Together, these 
results strongly indicate that the constructs were expressed in a correctly 
folded state, with the tetrameric channel forming successfully at the 
membrane. 
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6.1.2 Kvβ2 co-expression 
Attempts to generate a cell line for co-expression of Kv1.1 & Kvβ2 constructs 
were less successful than overexpression of Kv1.1 alone. Cells did not thrive 
long term in the presence of G-418, indicating that they either did not take up 
the plasmid, did not retain the plasmid for a long period, or suffered one or 
more fatal side-effects from uptake of the pcDNA3.1 plasmid. A repeat of 
transfection with G-418 concentrations reduced to 100 ng/µl, in line with 
results of the G-418 killing curve, did not improve viability of the cells. 
Further work must be done to establish what factors are causing doubly 
transfected cells to die. Placing doubly transfected cells into medium without 
antibiotic, as a positive control, would be advisable. If cells continue to die in 
the absence of antibiotic, this would indicate that cells are suffering ill-effects 
from the presence of the second plasmid, with death occurring independently 
of the presence of G-418. If cells survive, this would indicate the neomycin 
resistance gene encoded by the plasmid had failed to express, in which case 
it may be advisable to transfer the KCNAB2 gene out of the plasmid and into 
a new vector with functional antibiotic resistance. 
6.1.3 Suspension culture of HEK cells 
Experimental trials of suspension cultures for HEK 293S GnTI- were able to 
identify a number of conditions in which cells would thrive and replicate. Initial 
difficulties in the culturing of cells in DMEM were corrected through the 
introduction of additional serum to the medium, indicating that the calcium ion 
content of 10% FBS medium is not high enough to promote excessive 
clumping of cells. The addition of 2.5% (w/v) primatone and 0.2% (w/v) 
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pluronic acid were unable to achieve the same effect, indicating that the issues 
experienced were not the result of apoptosis, nor shearing of the cells. 
The cell culturing protocols developed during the course of this project 
provided reproducible methods for large scale culture of HEK cells. This was 
crucial for generating the quantity of protein required for structural study of the 
proteins. The ability to produce Kv1.1 in its native organism provided additional 
confidence in the quality of the protein going forward into subsequent steps. 
The quantity of pellet recovered from suspension culture per unit volume of 
medium used was equivalent to the quantity produced by adherent cell 
culture. Given that suspension cell culture often required higher investment of 
time and resources to conduct, it may be more efficient to revert to large scale 
adherent protocols in order to develop large quantities of cells more 
effectively. These shortcomings could be addressed in future by testing 
growth and expression in other vessels for human cell culture, such as 
bioreactor bags, roller flasks or larger scale adherent culture flasks.  
Initial challenges with cell growth and survival in DMEM during suspension 
culture were remedied by increasing the concentration of bovine serum in the 
medium from 1% (v/v) to 10% (v/v), in line media used in adherent cultures.  
Based on these results, it would be recommendable to begin suspension 
culture with related protein using serum concentrations at 10% (v/v). 
Many recent methodology papers on suspension culture techniques proscribe 
the use of expensive serum-free commercial suspension media, such as 
FreeStyle 293 or EX-CELL, with DMEM recommended only as a supplement 
to either, rather than a primary medium (De Los Milagros Bassani Molinas et 
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al. 2014, Goehring et al. 2014, Büssow 2015). It would likely benefit the 
scientific community at large that more research papers be published 
describing more cost-effective suspension protocols based on DMEM. This 
should be tempered however, by stressing the need to experiment with 
different medium types to identify the best protocol for expressing each 
protein. 
The recently published TRPC3 and TRPC6 channel structures both feature 
an alternative transfection regimen involving the viral BacMam vector for 
introduction of transgenic DNA to the host cell (Tang, Q. et al. 2018, Goehring 
et al. 2014). This approach may be worth adopting for experimentation, as 
short-term transfection in advance of harvesting might improve expression 
and cell viability by reducing stress on cells during early stages of culture. 
6.2 Protein purification and characterisation of Kv 
proteins 
6.2.1 Methods for primary purification 
The small-scale expression trials conducted early in this project, in 
combination with fluorescence microscopy, were able to confirm the presence 
of transgenic Kv1.1 expression. Polyhistidine-tagged protein extracted by 
detergent and maleic acid polymers were each purified on both nickel and 
cobalt-charged IMAC resins, with cobalt displaying the highest retention of 
protein. 
This result was unsurprising, as cobalt-based IMAC resins typically bind more 
broadly than nickel-based equivalents, leading to greater quantities of protein 
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in elution fractions, but ultimately less pure (Bornhorst and Falke 2000). As a 
result, effective secondary purification is essential in removing contaminants 
which follow the polyhistodine-tagged Kv1.1 through the process. However, 
the later difficulties experienced with TEV cleavage and SEC have rendered 
this approach less effective. 
Based on the setbacks experienced with secondary purification, 
experimentation with primary purification techniques could be employed to try 
and achieve a purer sample than has so far been accomplished with IMAC. 
Use of antibody-based resins with specificity for polyhistidine, GFP/EFYP or 
against Kv1.1 itself could be employed against the constructs which have been 
created to date. Further constructs with tags specifically designed as antibody 
epitopes, such as FLAG and nanotag (nTag), could also be used by modifying 
the construct with further tags. However, resins charged with antibodies are 
typically significantly more expensive than IMAC resins, making this approach 
less cost-effective. 
6.2.2 Methods for secondary purification  
6.2.2.1 TEV cleavage and reverse purification 
Identifying an efficient and cost-effective method for secondary purification of 
Kv1.1-TY10 was less straightforward than primary methods. Initial plans to 
reverse purify the protein on IMAC columns by removing the C-terminal tag 
using TEV digestion were hindered by an inability to reproduce the positive 
results observed in initial TEV cleavage trials. Successful digestion in initial 
trials may have been false positives caused by unfolding protein. 
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This may be due to the cleavage site being obscured by the flanking Kv1.1 
monomer and EYFP. If this is hypothesis is correct, the issue could be 
addressed by modifying the plasmid to add linker sequences ahead and 
behind the TEV cleavage site, limiting the chance of other domains obscuring 
the site. The early purification studies under which positive results for TEV 
cleavage were observed were not coupled with CD spectroscopy, thus it is 
unknown if the protein was fully folded in these earlier instances. If the TEV 
site is indeed being obscured by neighbouring domains, this could be 
addressed by modifying the Kv1.1-TY10 plasmid to extend the linker sequence 
bother upstream and downstream of the cleavage site. 
6.2.2.2 Size-exclusion chromatography 
Applying SEC as a secondary purification step in the preparation of the protein 
did not supply any visible results in SDS-PAGE or UV spectroscopic analysis 
of samples. It is possible that the Superdex 200 column and/or Åkta rig being 
used might be responsible either for binding the protein non-specifically and 
retaining, or a result of protein denaturation and precipitation leading Kv1.1 
eluting in earlier fractions off of the column. It is also possible that protein was 
diluted and became difficult to detect if the amount loaded onto the column 
was low in the first instance. 
6.2.3 Protein characterisation 
6.2.3.1 Mass spectrometry 
Protein identification of both Kv1.1, as well as a series of prominent 
contaminant bands from primary IMAC purification provided some insights 
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into the purification products. Most of the contaminating bands corresponded 
to proteins involved in protein folding/translocation (such as Hsp70) or 
associated with DNA. 
It should also be noted that Kv1.1 was prominently represented in fragments 
discovered in protein ID of band B3 (see Appendix 8.3.4). This is potentially 
significant, as the mass of this band is ~58 kDa, which corresponds to the 
expected mass of monomeric Kv1.1 following TEV cleavage. This points to the 
possibility that some of the product proteins might have lost their C-terminal 
tag, possibly through degradation or truncation of expression. 
The presence of a fragment aligning with the sequence of Kv1.3 was initially 
greeted as an exciting development, as it was taken to point to the presence 
of heterotetrameric channels forming between Kv1.1-TY10 and Kv1.3 
expressed endogenously by HEK 293S cells. However, this was tempered by 
the observation that only one fragment attributable to Kv1.3 was unique to it 
alone; all other fragments found in protein ID which aligned with KCNA3 also 
aligned with homologous regions of KCNA1, making it difficult to be certain 
how well represented Kv1.3 is represented in purified samples. 
The later realisation that the detected deamination of what was initially 
identified as Q188 residue of Kv1.3 could be alternately explained as a 
misidentification of the E121 residue of Kv1.1 lead to the abandonment of this 
explanation. It is therefore thought highly unlikely that Kv1.3 is present in the 
purified protein samples that were screened. 
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6.2.3.2 Circular dichroism 
The CD spectra of IMAC purified Kv1.1-TY10 indicated that the protein was 
folded and had a proportion of secondary structure expected for the protein, 
as well as included tags. The alignment of the predicted secondary structure 
content of the homology model with the results of CD analysis is compelling. 
It is difficult to say with certainty how accurate analysed CD data is, however, 
particularly because the protein samples used could not be purified further by 
any secondary purification methods which were attempted. As a result, 
interference by contaminating species cannot be entirely ruled out. CD 
spectroscopy should therefore be repeated once a method for producing purer 
sample has been developed. 
6.2.3.3 SEC-MALS 
The results of SEC-MALS did not match up well with those that we anticipated 
from our predictions about the Kv1.1 complex. MALS is inherently limited to 
discrete complexes and cannot differentiate between proteins and the lipid 
belts that surround membrane-spanning regions, making the hydrodynamic 
radius a poor metric for determining the boundaries of the complex without 
supplementary data (Sahin and Roberts 2012). 
More accurate estimations of the dimensions of the complex will require the 
application of other techniques. Small-angle neutron scattering (SANS) is a 
good candidate for approaching this topic, as it provides means of separately 
assessing the radius of different species, such as the proteins of the channel 
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complex as well as the lipids and detergent of the vesicular belt surrounding 
the membrane-spanning region. 
6.3 Structural analysis of homotetrameric Kv1.1 
6.3.1 Negative stain electron microscopy 
The structure generated from particles observed on DDM-solubilised samples 
of Kv1.1-TY10 matched well with the homology model of the tetrameric Kv1.1 
complex. The appearance of 4-fold symmetry in the model without the 
imposition of symmetry during processing was particularly encouraging. 
Based on this result, pursuit of a cryo-EM structure in DDM could produce 
materials suitable for publication in future. 
Additionally, the successful generation of a structure from negative stain 
micrographs of SMA-solubilised protein provides further evidence that Kv1.1 
is stably extracted by the polymer. This also constitutes a good avenue for 
further study, as a human membrane protein structure would be a novel result 
and a strong candidate for publication.  
The inability to produce a structure from DIBMA-solubilised sample was in line 
with results observed in CD data indicating that the DIBMA polymer is 
substantially less optimal for extraction than DDM or SMA. The reduced 
stability of Kv1.1 in DIBMA is the likely cause of the difficulties in producing 
data of sufficient quality for development of a structure. 
6.3.2 Cryo-electron microscopy 
As negative stain analysis has displayed some promise, cryo-EM analysis of 
samples was the logical extension of those studies. Although higher resolution 
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cryo-EM has additional challenges in the production of grids, such as blotting 
and freezing conditions, the potential to generate higher resolution maps 
makes it an inviting technique. 
A large number of cryo-EM grids were produced with a series of grid types 
across a series of blotting parameters, scaffold types and concentrations. 
However, screening and optimisation of procedures for improvement of 
datasets were hampered by early technical difficulties at the ABSL electron 
microscopy facility. 
Although a large dataset was collected from SMA-solubilised materials at the 
Diamond electron microscopy facility, the quality of the grids and subsequent 
micrographs were not sufficient for the generation of a high-resolution map. 
Future efforts towards the development of cryo-EM datasets could be 
improved with new technologies, for example phase plates and direct spraying 
of samples to grids. 
6.3.3 α-DTX co-incubated sample 
The addition of α-DTX to protein samples resulted in grids with high quantities 
of background stain which were difficult to analyse. This was likely due to 
ineffective removal of excess toxin during post-incubation dialysis, as the high 
affinity of α-DTX for Kv1.1 would make shedding of toxin back into solution 
unlikely. Longer dialysis times would therefore be advisable to remove excess 
of α-DTX. 
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6.4 Final Comments 
Membrane protein research is commonly affected by the particular challenges 
posed by their nature. The issues experienced with the cleavage of tags from 
Kv1.1, as well as interference from detergent, lipid and scaffold molecules with 
purification and characterisation of samples, while unfortunate was not 
unexpected. Difficulty with UV and visible light-based assays are a common 
issue with membrane protein research due to the overlap in the absorbance 
of proteins and lipids/detergent. The presence of large vesicular belts around 
the protein can obscure linker regions between domains and make cleavage 
sites inaccessible. 
While this project has exhibited a number of significant challenges, much work 
has been done in the development of methods for expressing Kv1.1. The 
results of extraction studies in DDM, SMA and DIBMA and CD spectroscopy 
of the recovered proteins represents a novel investigative study comparing 
their properties. Data relating to SMA and DIBMA is currently in preparation 
for publication as part of a larger collaboration with Dr. Vincent Postis 
comparing the effectiveness of maleic acid polymers across a series of 
membrane proteins. 
The comparison and evaluation of HEK cell culturing techniques conducted in 
the course of this project will provide a solid foundation for future expression 
of Kv1.1. A number of plasmids encoding both KCNA1 and KCNAB2 have 
been developed, which can be modified and experimented as necessary to 
improve the quality of expressed protein, as well as adjust the tags present on 
each protein to expand avenues for purification and characterisation. 
158 
 
Screening of cryo-EM grids under different blotting parameters and grid types 
should be continued now that the ABSL electron microscopy facility has 
become fully operational and initial issues with equipment and software have 
been addressed. Unfortunately, as much of the data was lost either to 
corruption or accidental loss in April 2017, much of the work involved will have 
to be repeated, however throughput of screening at the facility has now 
become much quicker, which will help with further efforts in data collection. 
Based on the results of CD spectroscopy and negative stain cryo-EM, it is 
likely that the DIBMA is not suitable for effective extraction of Kv1.1 from 
membranes. While this is disappointing, particularly in light of current industrial 
interest in DIBMA, both DDM and SMA are capable of extracting the protein 
and maintaining sufficient stability across purification and grid preparation for 
negative stain EM structures to be elucidated. Based on this result, it would 
be advisable to favour these two means of extraction for the time being, 
however it is also worth exploring other extraction techniques, such as 
amphipols and nanodiscs (Rouck et al. 2017, Le Bon et al. 2018). 
To conclude, the work conducted during the course of the project, as detailed 
in this thesis, provides a solid foundation for future studies on Kv1.1. The 
practical data on expression techniques for effective expression of Kv1.1 in 
human cells is also applicable to other projects focused on human membrane 
proteins and will be helpful in quickly establishing other projects on-site. 
Finally, the data on the application of DIBMA and SMA to human membrane 
proteins increases our overall understanding of the usefulness and 
applicability of these novel compounds to membrane protein preparation. 
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8 Appendix 
8.1 Maps of plasmids used during project 
8.1.1 pcDNA6 
 
Figure 8.1 – Map of pcDNA6 plasmid. 
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8.1.2 pcDNA3.1 
 
Figure 8.2 – Map of pcDNA3.1 plasmid. 
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8.1.3 pJET1.2 
 
Figure 8.3 – Map of pJET1.2 plasmid. 
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8.2 Mass spectrometry data 
8.2.1 A1 band 
 
Table 8.1 – Table of protein fragments identified through mass spectrometry in band A1 (Figure 4.8). 
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8.2.2 B1 band 
 
Table 8.2 – Table of protein fragments identified through mass spectrometry in band B1 (Figure 4.8). 
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8.2.3 B2 band 
 
Table 8.3 – Table of protein fragments identified through mass spectrometry in band B2 (Figure 4.8). 
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8.2.4 B3 band 
 
Table 8.4 – Table of protein fragments identified through mass spectrometry in band B3 (Figure 4.8). 
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8.2.5 B4 band 
 
Table 8.5 – Table of protein fragments identified through mass spectrometry in band B4 (Figure 4.8). 
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8.2.6 B5 band 
 
Table 8.6 – Table of protein fragments identified through mass spectrometry in band B5 (Figure 4.8). 
